<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27776130</article-id><article-id pub-id-type="pmc">5077078</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0164607</article-id><article-id pub-id-type="publisher-id">PONE-D-16-18103</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Neurodegenerative Diseases</subject><subj-group><subject>Movement Disorders</subject><subj-group><subject>Parkinson Disease</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Sensory Physiology</subject><subj-group><subject>Somatosensory System</subject><subj-group><subject>Pain Sensation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Sensory Physiology</subject><subj-group><subject>Somatosensory System</subject><subj-group><subject>Pain Sensation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Sensory Systems</subject><subj-group><subject>Somatosensory System</subject><subj-group><subject>Pain Sensation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Engineering and Technology</subject><subj-group><subject>Equipment</subject><subj-group><subject>Optical Equipment</subject><subj-group><subject>Lasers</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Brain</subject><subj-group><subject>Cingulate Cortex</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Brain</subject><subj-group><subject>Cingulate Cortex</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Brain Mapping</subject><subj-group><subject>Functional Magnetic Resonance Imaging</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Magnetic Resonance Imaging</subject><subj-group><subject>Functional Magnetic Resonance Imaging</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Magnetic Resonance Imaging</subject><subj-group><subject>Functional Magnetic Resonance Imaging</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Radiology and Imaging</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Magnetic Resonance Imaging</subject><subj-group><subject>Functional Magnetic Resonance Imaging</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Functional Magnetic Resonance Imaging</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Functional Magnetic Resonance Imaging</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Sensory Perception</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Psychology</subject><subj-group><subject>Sensory Perception</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social Sciences</subject><subj-group><subject>Psychology</subject><subj-group><subject>Sensory Perception</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Pain</subject><subj-group><subject>Neuropathic Pain</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Pain</subject><subj-group><subject>Neuropathic Pain</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pain Management</subject><subj-group><subject>Myalgia</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Central Pain Processing in Early-Stage Parkinson's Disease: A Laser Pain fMRI Study</article-title><alt-title alt-title-type="running-head">Pain Processing in Early-Stage Parkinson's Disease</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Petschow</surname><given-names>Christine</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Scheef</surname><given-names>Lukas</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Paus</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zimmermann</surname><given-names>Nadine</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schild</surname><given-names>Hans H.</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Klockgether</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Boecker</surname><given-names>Henning</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Functional Neuroimaging Group, Department of Radiology, University of Bonn, Bonn, Germany</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Department of Neurology, University of Bonn, Bonn, Germany</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Department of Radiology, University of Bonn, Bonn, Germany</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Arias-Carrion</surname><given-names>Oscar</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Hospital General Dr. Manuel Gea Gonzalez, MEXICO</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>C. Petschow received research support from the BONFOR SciMed-Promotionsstipendium of the university of Bonn. L. Scheef has no relevant financial relationships with commercial interest to disclosure. S. Paus is an employer of the University Clinic of Bonn. He has received research grants from Ipsen Pharma and Merz Pharmaceuticals. He is a member of the Advisory Boards of Allergan, Ipsen Pharma and Merz Pharmaceuticals. He has received lecturer fees from Allergan, Ipsen Pharma and Merz Pharmaceuticals. N. Zimmermann has no relevant financial relationships with commercial interest to disclosure. H. Schild has received funding from the Deutsche Forschungsgemeinschaft and the Bundesministerium f&#x000fc;r Bildung und Forschung (BMBF). T. Klockgether receives/has received research support from the Deutsche Forschungsgemeinschaft (DFG), the Bundesministerium f&#x000fc;r Bildung und Forschung (BMBF), the Robert Bosch Foundation and the European Union (EU). He serves on the editorial board of The Cerebellum. He has received a consulting fee from ICON Clinical Research. H. Boecker receives/has received research support from the Deutsche Forschungsgemeinschaft (DFG) and the Bundesministerium fu?r Bildung und Forschung (BMBF). He has received a lecturer fee from the National Paralympic Committee Germany and royalties from Springer, NY. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> CP LS SP HHS TK HB.</p></list-item><list-item><p><bold>Data curation:</bold> CP LS.</p></list-item><list-item><p><bold>Formal analysis:</bold> CP LS HB.</p></list-item><list-item><p><bold>Funding acquisition:</bold> CP HB.</p></list-item><list-item><p><bold>Investigation:</bold> CP LS SP NZ HB.</p></list-item><list-item><p><bold>Methodology:</bold> CP LS HB.</p></list-item><list-item><p><bold>Project administration:</bold> HB CP.</p></list-item><list-item><p><bold>Resources:</bold> SP NZ HHS TK HB.</p></list-item><list-item><p><bold>Software:</bold> CP LS.</p></list-item><list-item><p><bold>Supervision:</bold> HB LS.</p></list-item><list-item><p><bold>Validation:</bold> CP LS HB.</p></list-item><list-item><p><bold>Visualization:</bold> CP HB.</p></list-item><list-item><p><bold>Writing &#x02013; original draft:</bold> CP HB.</p></list-item><list-item><p><bold>Writing &#x02013; review &#x00026; editing:</bold> LS SP NZ HHS TK HB.</p></list-item></list></p></fn><corresp id="cor001">* E-mail: <email>henning.boecker@ukb.uni-bonn.de</email></corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>10</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>11</volume><issue>10</issue><elocation-id>e0164607</elocation-id><history><date date-type="received"><day>4</day><month>5</month><year>2016</year></date><date date-type="accepted"><day>28</day><month>9</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Petschow et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Petschow et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0164607.pdf"/><abstract><sec id="sec001"><title>Background &#x00026; Objective</title><p>Pain is a common non-motor symptom in Parkinson&#x02019;s disease. As dopaminergic dysfunction is suggested to affect intrinsic nociceptive processing, this study was designed to characterize laser-induced pain processing in early-stage Parkinson&#x02019;s disease patients in the dopaminergic OFF state, using a multimodal experimental approach at behavioral, autonomic, imaging levels.</p></sec><sec id="sec002"><title>Methods</title><p>13 right-handed early-stage Parkinson&#x02019;s disease patients without cognitive or sensory impairment were investigated OFF medication, along with 13 age-matched healthy control subjects. Measurements included warmth perception thresholds, heat pain thresholds, and central pain processing with event-related functional magnetic resonance imaging (erfMRI) during laser-induced pain stimulation at lower (E = 440 mJ) and higher (E = 640 mJ) target energies. Additionally, electrodermal activity was characterized during delivery of 60 randomized pain stimuli ranging from 440 mJ to 640 mJ, along with evaluation of subjective pain ratings on a visual analogue scale.</p></sec><sec id="sec003"><title>Results</title><p>No significant differences in warmth perception thresholds, heat pain thresholds, electrodermal activity and subjective pain ratings were found between Parkinson&#x02019;s disease patients and controls, and erfMRI revealed a generally comparable activation pattern induced by laser-pain stimuli in brain areas belonging to the central pain matrix. However, relatively reduced deactivation was found in Parkinson&#x02019;s disease patients in posterior regions of the default mode network, notably the precuneus and the posterior cingulate cortex.</p></sec><sec id="sec004"><title>Conclusion</title><p>Our data during pain processing extend previous findings suggesting default mode network dysfunction in Parkinson&#x02019;s disease. On the other hand, they argue against a genuine pain-specific processing abnormality in early-stage Parkinson&#x02019;s disease. Future studies are now required using similar multimodal experimental designs to examine pain processing in more advanced stages of Parkinson&#x02019;s disease.</p></sec></abstract><funding-group><award-group id="award001"><funding-source><institution>BONFOR</institution></funding-source><award-id>SciMed- Promotionsstipendium O-141.0015</award-id><principal-award-recipient><name><surname>Petschow</surname><given-names>Christine</given-names></name></principal-award-recipient></award-group><funding-statement>C. Petschow received research support from the BONFOR SciMed-Promotionsstipendium of the university of Bonn. L. Scheef has no relevant financial relationships with commercial interest to disclosure. S. Paus is an employer of the University Clinic of Bonn. He has received research grants from Ipsen Pharma and Merz Pharmaceuticals. He is a member of the Advisory Boards of Allergan, Ipsen Pharma and Merz Pharmaceuticals. He has received lecturer fees from Allergan, Ipsen Pharma and Merz Pharmaceuticals. N. Zimmermann has no relevant financial relationships with commercial interest to disclosure. H. Schild has received funding from the Deutsche Forschungsgemeinschaft and the Bundesministerium f&#x000fc;r Bildung und Forschung (BMBF). T. Klockgether receives/has received research support from the Deutsche Forschungsgemeinschaft (DFG), the Bundesministerium f&#x000fc;r Bildung und Forschung (BMBF), the Robert Bosch Foundation and the European Union (EU). He serves on the editorial board of The Cerebellum. He has received a consulting fee from ICON Clinical Research. H. Boecker receives/has received research support from the Deutsche Forschungsgemeinschaft (DFG) and the Bundesministerium f&#x000fc;r Bildung und Forschung (BMBF). He has received a lecturer fee from the National Paralympic Committee Germany and royalties from Springer, NY.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="5"/><page-count count="18"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>Ethical permission for public sharing of the anonymized fMRI and behavioral data was not part of our existing ethical permission of the study. Data are available upon request. Data can be obtained by a request to Professor H. Boecker (<email>henning.boecker@ukb.uni-bonn.de</email>).</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>Ethical permission for public sharing of the anonymized fMRI and behavioral data was not part of our existing ethical permission of the study. Data are available upon request. Data can be obtained by a request to Professor H. Boecker (<email>henning.boecker@ukb.uni-bonn.de</email>).</p></notes></front><body><sec sec-type="intro" id="sec005"><title>Introduction</title><p>Parkinson&#x02019;s disease (PD) is a neurodegenerative disorder causing progressive deterioration of motor function [<xref rid="pone.0164607.ref001" ref-type="bibr">1</xref>]. So-called &#x02018;non-motor symptoms&#x02019; [<xref rid="pone.0164607.ref002" ref-type="bibr">2</xref>&#x02013;<xref rid="pone.0164607.ref006" ref-type="bibr">6</xref>] are nowadays increasingly recognized as integral components of PD, including cognitive [<xref rid="pone.0164607.ref007" ref-type="bibr">7</xref>], mood [<xref rid="pone.0164607.ref008" ref-type="bibr">8</xref>], autonomic [<xref rid="pone.0164607.ref009" ref-type="bibr">9</xref>], and sleep [<xref rid="pone.0164607.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0164607.ref011" ref-type="bibr">11</xref>] disturbances. Although pain symptoms are less widely appreciated as non-motor manifestations of PD, already the original description of &#x02018;the shaking palsy&#x02019; by James Parkinson identified pain as part of the clinical symptomatology, often occurring as one of the first signs at disease onset [<xref rid="pone.0164607.ref012" ref-type="bibr">12</xref>]. Pain in PD is under recognized and undertreated [<xref rid="pone.0164607.ref013" ref-type="bibr">13</xref>], affecting roughly 40&#x02013;60% of PD patients [<xref rid="pone.0164607.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0164607.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0164607.ref013" ref-type="bibr">13</xref>&#x02013;<xref rid="pone.0164607.ref019" ref-type="bibr">19</xref>], and is linked to depression, decreased quality of life [<xref rid="pone.0164607.ref020" ref-type="bibr">20</xref>], female gender, age, disease duration and severity [<xref rid="pone.0164607.ref016" ref-type="bibr">16</xref>]. According to Ford [<xref rid="pone.0164607.ref014" ref-type="bibr">14</xref>], pain in PD can be differentiated into: (i) musculoskeletal pain, (ii) radicular, or neuropathic pain, (iii) dystonia-related pain, (iv) akathitic discomfort, and (v) primary, or central parkinsonian pain. A study involving 176 home-living PD patients [<xref rid="pone.0164607.ref013" ref-type="bibr">13</xref>] found elevated pain levels on the &#x02018;Bodily Pain Scale&#x02019;, with musculoskeletal pain making up 70%, followed by dystonic pain (40%), radicular-neuropathic pain (20%), and central neuropathic pain (10%).</p><p>The concept of &#x02018;primary parkinsonian pain&#x02019; independent of PD motor symptoms was initially outlined by Souques in 1921 describing bizarre stabbing and burning sensations [<xref rid="pone.0164607.ref021" ref-type="bibr">21</xref>]. It is understood as a primary dysfunction of central pain pathways and is attributed to central dopamine loss, as it occurs frequently in untreated patients or during &#x0201c;OFF&#x0201d; periods, and is modifiable by dopamine substitution [<xref rid="pone.0164607.ref022" ref-type="bibr">22</xref>]. Schestatsky et al. provided a neurophysiological characterization in nine PD patients with primary central pain, as compared to 9 PD patients without pain, and 9 healthy control subjects [<xref rid="pone.0164607.ref023" ref-type="bibr">23</xref>]. PD patients with primary central pain had lower heat pain and laser pinprick thresholds, higher laser-evoked pain amplitudes, and less habituation of the laser-induced sudomotor skin responses than PD patients without pain and control subjects [<xref rid="pone.0164607.ref023" ref-type="bibr">23</xref>]. Abnormalities in pain processing were attenuated after L-Dopa substitution [<xref rid="pone.0164607.ref023" ref-type="bibr">23</xref>], implicating &#x02018;primary parkinsonian pain&#x02019; to be a direct consequence of the hypodopaminergic state in PD. Likewise, pain in PD can be provoked by dopamine agonist withdrawal [<xref rid="pone.0164607.ref024" ref-type="bibr">24</xref>].</p><p>The neuronal mechanisms mediating pain processing in PD are as yet not well understood. Functional neuroimaging has been relevant for delineating central mechanisms underlying motor [<xref rid="pone.0164607.ref025" ref-type="bibr">25</xref>&#x02013;<xref rid="pone.0164607.ref028" ref-type="bibr">28</xref>] and cognitive [<xref rid="pone.0164607.ref029" ref-type="bibr">29</xref>&#x02013;<xref rid="pone.0164607.ref031" ref-type="bibr">31</xref>] disturbances in PD. More recent imaging research has also focused on non-motor sensory aspects [<xref rid="pone.0164607.ref032" ref-type="bibr">32</xref>,<xref rid="pone.0164607.ref033" ref-type="bibr">33</xref>] of the pathophysiological spectrum (for review see: [<xref rid="pone.0164607.ref034" ref-type="bibr">34</xref>]). Central pain processing in PD has, however, exclusively been addressed by one previous positron emission tomography (PET) H<sub>2</sub><sup>15</sup>O activation study. Brefel-Courbon et al. compared pain thresholds before and after administration of levodopa in nine PD patients and nine controls, along with cerebral activity during experimental nociceptive stimulation [<xref rid="pone.0164607.ref035" ref-type="bibr">35</xref>]. In the OFF, pain thresholds were significantly lower than in the control cohort, but levodopa medication raised these thresholds significantly. The OFF was associated with relatively increased pain-evoked activation of the insula, prefrontal cortex and anterior cingulate cortex, which was attenuated by L-dopa treatment. These examinations in a rather small cohort provided interesting first indications that L-dopa administration modulates pain responses and pain thresholds in PD [<xref rid="pone.0164607.ref035" ref-type="bibr">35</xref>]. A major limitation, however, is the very liberal level of significance (p &#x0003c; 0.01, uncorrected), questioning the general validity and reproducibility of the reported findings. Also, the authors did not test for the presence of Parkinson-associated neuropathies [<xref rid="pone.0164607.ref036" ref-type="bibr">36</xref>], which may affect the propagation of standardized nociceptive stimuli into the parkinsonian brain, hence, introducing variance of peripheral, rather than central origin.</p><p>Here, we intended to resolve the above mentioned ambiguities, (i) by excluding patients with polyneuropathy, (ii) by using event-related functional magnetic resonance imaging (fMRI) with its intrinsically higher spatial resolution compared to PET, (iii) by applying conservative statistical thresholds, (iv) by combining imaging with standardized heat pain threshold measurements, psychophysiological pain intensity ratings, and skin-conductance measurements. We focused exclusively on OFF state examinations, as we primarily conceived to trace potential abnormalities of central pain processing in PD patients, using a multilevel experimental approach.</p></sec><sec sec-type="materials|methods" id="sec006"><title>Methods</title><sec id="sec007"><title>Subjects</title><p>In a telephone call subjects were informed about study objective as well as procedure and were interviewed about exclusion criteria which were psychotropic substance abuse, medication affecting pain perception, psychiatric disorders, diabetes mellitus, and evidence of peripheral neuropathy. At a first visit interested subjects were informed about the study procedure again. After subjects gave a first written informed consent for pretests they underwent an electroneurographic polyneuropathy screening.</p><p>We screened a total of N = 83 persons (N = 43 PD; N = 40 healthy controls) for potential enrollment into the study and had to rule out four cases with preexisting claustrophobia, seven cases with severe psychiatric disorders, two cases with tinnitus, six cases with missing interest in finally participating in the study, and two cases with metallic implants. Of these, another 10 PD patients and 9 healthy controls had to be excluded because of peripheral neuropathy evidenced in the electrophysiological workup. 6 PD patients and 7 healthy controls withdrew participation during different recruitment stages.</p><p>After screening, 15 healthy controls (HC) and 15 patients with the clinical diagnosis of idiopathic PD according to the diagnostic criteria of the UK-Parkinson&#x02019;s Diseases Society Brain-Bank [<xref rid="pone.0164607.ref037" ref-type="bibr">37</xref>] could be enrolled. All subjects gave a second written informed consent to the study examinations. One PD patient and one healthy control had to be excluded after enrollment in the MRI study due to claustrophobia (2). Incidental MRI findings were found in one further PD and one further HC, resulting in a total sample with complete and analyzable data of 13 HC (four female, nine male, mean age 54.46 &#x000b1; 9.60 years) and 13 PD (four female, nine male, mean age 48.62 &#x000b1; 5.85 years; for clinical details see <xref ref-type="table" rid="pone.0164607.t001">Table 1</xref>). All subjects were right-handed [<xref rid="pone.0164607.ref038" ref-type="bibr">38</xref>]. At a second visit subjects took part in the following study procedure (<xref ref-type="fig" rid="pone.0164607.g001">Fig 1</xref>). Patients were studied after &#x0003e; 12 hours overnight treatment withdrawal.</p><fig id="pone.0164607.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0164607.g001</object-id><label>Fig 1</label><caption><title>Procedure of subject recruitment and pain imaging study.</title><p>Subject recruitment included a first telephone interview and was followed by a first visit for an electroneurographic polyneuropathy screening. At a second visit enrolled subjects underwent the experimental pain study, consisting of psychological questionnaires, clinical tests, quantitative sensory testing, event related fMRI, and behavioral pain testings.</p></caption><graphic xlink:href="pone.0164607.g001"/></fig><table-wrap id="pone.0164607.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0164607.t001</object-id><label>Table 1</label><caption><title>Clinical characterization of patients with early-stage idiopathic Parkinson&#x02019;s disease.</title></caption><alternatives><graphic id="pone.0164607.t001g" xlink:href="pone.0164607.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Patient no.</th><th align="left" rowspan="1" colspan="1">Sex</th><th align="left" rowspan="1" colspan="1">Age</th><th align="left" rowspan="1" colspan="1">Years of disease duration</th><th align="left" rowspan="1" colspan="1">PANDA cognition</th><th align="left" rowspan="1" colspan="1">PANDA mood</th><th align="left" rowspan="1" colspan="1">UPDRS I</th><th align="left" rowspan="1" colspan="1">UPDRS II</th><th align="left" rowspan="1" colspan="1">UPDRS III</th><th align="left" rowspan="1" colspan="1">UPDRS IV</th><th align="left" rowspan="1" colspan="1">UPDRS total</th><th align="left" rowspan="1" colspan="1">HY stage</th><th align="left" rowspan="1" colspan="1">Pharmacological treatment</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">P01</td><td align="left" rowspan="1" colspan="1">m</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">LD, RGN, RPN</td></tr><tr><td align="left" rowspan="1" colspan="1">P02</td><td align="left" rowspan="1" colspan="1">m</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">AMN, LD, SGN, PPX</td></tr><tr><td align="left" rowspan="1" colspan="1">P03</td><td align="left" rowspan="1" colspan="1">m</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">RGN</td></tr><tr><td align="left" rowspan="1" colspan="1">P04</td><td align="left" rowspan="1" colspan="1">m</td><td align="left" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">PPX, RGN</td></tr><tr><td align="left" rowspan="1" colspan="1">P05</td><td align="left" rowspan="1" colspan="1">m</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">AMN, PPX, RGN</td></tr><tr><td align="left" rowspan="1" colspan="1">P06</td><td align="left" rowspan="1" colspan="1">m</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">CD, EC, LD, PPX, RGN</td></tr><tr><td align="left" rowspan="1" colspan="1">P07</td><td align="left" rowspan="1" colspan="1">f</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">CD, LD, RGN, RPN</td></tr><tr><td align="left" rowspan="1" colspan="1">P08</td><td align="left" rowspan="1" colspan="1">m</td><td align="left" rowspan="1" colspan="1">42</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">2.0</td><td align="left" rowspan="1" colspan="1">CD, LD, RGN</td></tr><tr><td align="left" rowspan="1" colspan="1">P09</td><td align="left" rowspan="1" colspan="1">m</td><td align="left" rowspan="1" colspan="1">43</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">CD, AMN, LD, SGN,</td></tr><tr><td align="left" rowspan="1" colspan="1">P10</td><td align="left" rowspan="1" colspan="1">f</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">2.0</td><td align="left" rowspan="1" colspan="1">AMN, PPX, SGN</td></tr><tr><td align="left" rowspan="1" colspan="1">P11</td><td align="left" rowspan="1" colspan="1">f</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">CD, LD, BP</td></tr><tr><td align="left" rowspan="1" colspan="1">P12</td><td align="left" rowspan="1" colspan="1">m</td><td align="left" rowspan="1" colspan="1">57</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">LD, PPX, RGN</td></tr><tr><td align="left" rowspan="1" colspan="1">P13</td><td align="left" rowspan="1" colspan="1">f</td><td align="left" rowspan="1" colspan="1">59</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">CD, LD, RGN</td></tr><tr><td align="left" rowspan="1" colspan="1">M</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">48.62</td><td align="left" rowspan="1" colspan="1">4.46</td><td align="left" rowspan="1" colspan="1">24.85</td><td align="left" rowspan="1" colspan="1">1.77</td><td align="left" rowspan="1" colspan="1">1.08</td><td align="left" rowspan="1" colspan="1">7.08</td><td align="left" rowspan="1" colspan="1">13.31</td><td align="left" rowspan="1" colspan="1">1.62</td><td align="left" rowspan="1" colspan="1">23.08</td><td align="left" rowspan="1" colspan="1">1.27</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000b1; SD</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x000b1; 5.85</td><td align="left" rowspan="1" colspan="1">&#x000b1; 1.94</td><td align="left" rowspan="1" colspan="1">&#x000b1; 5.05</td><td align="left" rowspan="1" colspan="1">&#x000b1; 1.36</td><td align="left" rowspan="1" colspan="1">&#x000b1; 1.11</td><td align="left" rowspan="1" colspan="1">&#x000b1; 3.95</td><td align="left" rowspan="1" colspan="1">&#x000b1; 4.44</td><td align="left" rowspan="1" colspan="1">&#x000b1; 1.81</td><td align="left" rowspan="1" colspan="1">&#x000b1; 7.25</td><td align="left" rowspan="1" colspan="1">&#x000b1; 0.39</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Clinical test data were collected after at least 12 hours withdrawal of pharmacological antiparkinsonian treatment.</p></fn><fn id="t001fn002"><p>AMN: amantadine, BP: biperiden, CD: carbidopa, EC: entacapone, f: female, LD: L-dopa, M: mean, m: male, PANDA: Parkinson Neuropsychometric Dementia Assessment, PPX: pramipexole, RGN: rasagiline, RPN: ropinirole, SD: standard deviation, SGN: selegiline, UPDRS: Unified Parkinson&#x02019;s Disease Rating Scale, HY stage: Hoehn &#x00026; Yahr stage.</p></fn></table-wrap-foot></table-wrap><p>The study was approved by the local Ethics Committee of the University Hospital of Bonn, Germany (reference number 115/11). All participants gave written informed consent and were recruited between November 2012 and October 2014.</p></sec><sec id="sec008"><title>Psychological questionnaires and clinical tests</title><p>Psychological and clinical tests included Beck Depression Inventory (BDI-II) [<xref rid="pone.0164607.ref039" ref-type="bibr">39</xref>], Mini International Neuropsychiatric Interview (MINI) [<xref rid="pone.0164607.ref040" ref-type="bibr">40</xref>], Mini-Mental State Examination (MMSE) [<xref rid="pone.0164607.ref041" ref-type="bibr">41</xref>], German vocabulary test (Wortschatztest, WST) [<xref rid="pone.0164607.ref042" ref-type="bibr">42</xref>] and State-Trait Anxiety Inventory (STAI) [<xref rid="pone.0164607.ref043" ref-type="bibr">43</xref>]. PD patients were clinically examined using the Unified Parkinson&#x02019;s Disease Rating Scale (UPDRS) [<xref rid="pone.0164607.ref044" ref-type="bibr">44</xref>] and the Hoehn &#x00026; Yahr Scale [<xref rid="pone.0164607.ref045" ref-type="bibr">45</xref>] in the OFF state. Disease specific cognitive deficits were evaluated using the Parkinson Neuropsychometric Dementia Assessment (PANDA) [<xref rid="pone.0164607.ref046" ref-type="bibr">46</xref>].</p><p>Group differences of normally distributed values (age, STAI-state, WST) were compared by two-sample t-tests, whereas group differences of values that were not normally distributed (distribution skewed, Shapiro-Wilk-Test: p &#x0003c; 0.01) were tested nonparametrically by the Mann-Whitney U test (BDI, EHI, MMSE). Statistical analysis was performed with SPSS Statistics 22 (IBM, USA) and values are presented as mean &#x000b1; standard deviation. Statistical significance was considered at a threshold of p &#x0003c; 0.05.</p></sec><sec id="sec009"><title>Pain and sensory threshold recordings</title><p>Individual warmth perception thresholds (WPT) and heat pain thresholds (HPT) were examined with the Medoc TSA-II (Medoc, Ramat. Yishai, Israel) thermal pain stimulation device (&#x0201c;ascending methods of limits&#x0201d; option; starting temperature 32&#x000b0;C, rise time 0.5&#x000b0;C/s). Warmth sensation was induced by a 9 cm<sup>2</sup> Peltier thermode, centered on right volar forearm. For WPT, subjects signaled the first-time warmth sensation by a button press. For HPT, subjects signaled the first-time pain sensation. Subjects were familiarized with the procedure performing three test trials, the five following main trials were averaged to determine the individual WPT and HPT [<xref rid="pone.0164607.ref047" ref-type="bibr">47</xref>,<xref rid="pone.0164607.ref048" ref-type="bibr">48</xref>].</p></sec><sec id="sec010"><title>FMRI paradigm</title><p>According to published implementations of laser heat pain stimulation in fMRI [<xref rid="pone.0164607.ref049" ref-type="bibr">49</xref>&#x02013;<xref rid="pone.0164607.ref051" ref-type="bibr">51</xref>], a &#x0201c;Low Pain&#x0201d; laser stimulus with lower energy (LPS, E = 440 mJ) and a &#x0201c;High Pain&#x0201d; laser stimulus with higher energy (HPS, E = 640 mJ) were applied to right foot dorsum by a Thulium(Tm)-YAG-Laser (THEMIS, StarMedTec GmbH, Starnberg, Germany). After each stimulus, the application unit was moved about 1 cm within a 3 x 3 cm surface. First, 3 LPS and 3 HPS were applied outside the scanner to familiarize subjects with the pain stimulation. The perceived pain intensity of each test stimulus was evaluated on a 10 cm visual analogue scale (VAS, 0 cm &#x0201c;no pain&#x0201d;, 10 cm &#x0201c;most severe imaginable pain&#x0201d;). VAS values of the 3 LPS and 3 HPS were averaged as a measure of individually perceived pain intensity during application of test stimuli. During fMRI, subjects received 40 LPS in a first session, followed by 30 HPS in a second session. This approach was chosen to minimize uncertainty and associated expectation effects for upcoming painful stimuli. The interstimulus interval was randomized between 10 s to 20 s (mean LPS session 15.59 s, mean HPS session 15.43 s). Stimulus evaluation was not implemented in the fMRI paradigm to minimize cognitive influences on the imaging data.</p></sec><sec id="sec011"><title>FMRI acquisition, preprocessing, and analysis</title><p>MRI was performed on a 3T scanner (Ingenia, Philips, Best, The Netherlands) equipped with an 8-channel SENSE head coil. T2*-weighted echo planar imaging (EPI) sequences were acquired (repetition time (TR) = 2595 ms, echo time (TE) = 35 ms, flip angle = 90&#x000b0;, field of view (FOV) = 230 x 230 x 147mm<sup>3</sup>, voxel size = 3.6 x 3.6 x 3.6 mm<sup>3</sup>, 41 axial slices in interleaved ascending mode). Scan duration was 11 min 7 s (LPS session) and 8 min 5 s (HPS session), resulting in 250 LPS and 180 HPS volumes per subject. This difference arose from piloting data which indicated lower skin conductance response (SCR) detection rates for LP compared to HP stimulation. In this data, an SCR could be measured in 80% of the applied LPS and in 100% of the applied HPS. Accordingly, LP stimuli number was adapted (40 low pain stimuli vs. 30 high pain stimuli). A high-resolution T1-weighted 3D-MPRAGE sequence (TI = 1300 ms, TR = 7.7 ms, TE = 3.9 ms, flip angle = 15&#x000b0;; FOV = 256 &#x000d7; 256 &#x000d7; 180 mm<sup>3</sup>, isotropic voxel resolution = 1 &#x000d7; 1 &#x000d7; 1 mm<sup>3</sup>, 180 slices, duration: 4 min 39 s) was acquired for anatomical reference and spatial normalization. The overall scanning duration including additional sequences (resting brain: 11 min 7 s, 3D-T2: 6 min 3 s, FLAIR: 5 min 31 s, and DTI: 8 min 38 s) was 55 min 10 s.</p><p>Preprocessing and analysis were performed with SPM8 (Wellcome Department of Imaging Neuroscience, London, UK) including slice-timing correction, realignment to the first volume, spatial normalization and smoothing (8 x 8 x 8 mm<sup>3</sup>). Exclusion criteria for imaging data were translational movements above the half-voxel resolution. However, no imaging data had to be excluded for movement artifacts. The first level design matrix consisted of the pain stimulation onsets convolved with the canonical hrf as implemented in SPM8 and six motion regressor derived from the realignment as nuisance factors. Both sessions (session 1: LPS, session 2: HPS) were in one model as separate sessions. The two contrast images contained the statistical effects of pain against baseline (LPS and HPS) and were used for further analysis at second level. Per group main pain effects of LPS and HPS were analyzed by use of a one-sample t-test. Between-group analysis was performed with a two-sample t-test for LPS and HPS condition separately. Statistical significance was considered for voxels exceeding a threshold of p &#x0003c; 0.05 (corrected for family wise errors at cluster level). Significant activations were localized using SPM Anatomy Toolbox Version 2.0 [<xref rid="pone.0164607.ref052" ref-type="bibr">52</xref>] and MRIcron (Version 6.6.2013, Chris Rorden, <ext-link ext-link-type="uri" xlink:href="http://www.mricro.com/">www.mricro.com</ext-link>).</p></sec><sec id="sec012"><title>Behavioral data</title><p>Subjects were instructed to evaluate 60 laser-pain stimuli on a VAS. In total, 10 x 6 randomized laser heat pain stimuli with an energy of 440 mJ (LPS), 480 mJ, 520 mJ, 560 mJ, 600 mJ and 640 mJ (HPS) were applied to the right foot dorsum with an varying interstimulus interval (ISI) between 10 s to 20 s (mean ISI 16.1 s). During the ISI an evaluation of the pain stimuli followed using a VAS. VAS values were averaged for each of the six different pain stimuli. Group differences between the not normally distributed values of VAS (distribution skewed, Shapiro-Wilk-Test: p &#x0003c; 0.001) were investigated nonparametrically by the Mann-Whitney U test. Intra-group differences of VAS values were tested with the Friedman test plus post hoc testing. Linear correlations between target energy and VAS values were investigated by Spearman&#x02019;s correlation coefficient.</p></sec><sec id="sec013"><title>SCR data</title><p>During the behavioral assessment, we simultaneously acquired the SCR [<xref rid="pone.0164607.ref053" ref-type="bibr">53</xref>]. Ag/AgCl electrodes (BIOPAC Systems, Inc.) were attached to the palmar index and the middle finger of the left hand. Data was acquired with the data acquisition unit MP150 (BIOPAC Systems, Inc.). Electrodermal Activity (EDA) was recorded in DC mode (gain 5 &#x003bc;mho/V, low pass filter 1 Hz, sampling rate 100 Hz) and processed with AcqKnowledge Version 4.1 (BIOPAC Systems, Inc.) using the &#x0201c;Event-related EDA Analysis&#x0201d; option (high-pass filter of 0.05 Hz). SCR amplitudes were defined as the difference between maximum and baseline responses within a time window of 1&#x02013;4 s after stimulus onset and rise times of 1&#x02013;3 s [<xref rid="pone.0164607.ref054" ref-type="bibr">54</xref>]. Data was transformed logarithmically. SCR magnitudes were estimated for each of the six pain stimuli and standardized by z-transformation.</p><p>Group differences concerning standardized SCR magnitudes were compared by two-sample t-tests. Intra-group differences of SCR-magnitudes were tested by a one-way analysis of variance (ANOVA) with repeated measures and Bonferroni corrected post hoc tests. Linear correlations between target energy and SCR magnitude were investigated by Pearson&#x02019;s correlation coefficient.</p><p>One PD patient and one control subject were excluded from EDA analysis due to artificial EDA data.</p></sec></sec><sec sec-type="results" id="sec014"><title>Results</title><sec id="sec015"><title>Clinical and neuropsychological characterization</title><p>None of the participants showed results indicating psychiatric diseases (MINI). MMSE results of both groups showed no cognitive deficits (score &#x02265; 27 points) or significant group differences regarding cognitive capacity (PD: 29.38 &#x000b1; 0.96 points; HC: 29.77 &#x000b1; 0.44 points; U = 68.50, p = 0.418).</p><p>Significant group differences were observed for BDI-II, STAI-state and WST. PD had significantly higher scores in BDI (PD: 5.62 &#x000b1; 3.45 points, range 0&#x02013;11 points; HC: 1.46 &#x000b1; 1.85 points, range 0&#x02013;6 points; U = 143.5, p = 0.002), STAI-state (PD: 35.85 &#x000b1; 8.09 points; HC: 26.85 &#x000b1; 4.36 points, t(24) = 3.53, p = 0.002), and significantly lower scores in WST (PD: 103.15 &#x000b1; 11.10 points; HC: 112.46 &#x000b1; 11.04 points; t(24) = -2.14, p = 0.042).</p><p>The PANDA test yielded consistent results, both for cognition and mood (<xref ref-type="table" rid="pone.0164607.t001">Table 1</xref>). Although one PD patient showed a score of 14 points at the threshold level (PANDA cognition part), the subject was not excluded due to a normal MMSE score. To consider possible effects of increased situational anxiety and different mood states, we performed additional fMRI models with BDI and STAI-state scores as covariates at the second level.</p></sec><sec id="sec016"><title>Warmth perception and thermal heat pain threshold</title><p>Temperatures of WPT and HPT did not differ significantly between PD and HC (WPT<sub>PD</sub>: 33.83 &#x000b1; 1.02&#x000b0;C vs. WPT<sub>HC</sub>: 34.01 &#x000b1; 1.65&#x000b0;C, t(24) = -0.33, p = 0.741; HPT<sub>PD</sub>: 44.71 &#x000b1; 1.91&#x000b0;C vs. HPT<sub>HC</sub>: 45.97 &#x000b1; 1.40&#x000b0;C, t(24) = -1.93, p = 0.066).</p></sec><sec id="sec017"><title>Evaluation of laser stimuli with different target energies</title><p>The evaluation of the pain stimuli with six different target energies (each applied 10 times) didn&#x02019;t result in significant group differences of VAS values (<xref ref-type="table" rid="pone.0164607.t002">Table 2</xref>). In both groups, post hoc tests showed that HPS was evaluated by significant higher VAS values than LPS (PD: p &#x0003c; 0.001; HC: p &#x0003c; 0.001). Target energy and VAS values were significantly correlated (PD: rs = 0.60, p &#x0003c; 0.001; HC: rs = 0.63, p &#x0003c; 0.001). The correlation between target energy and VAS values was not significantly different between PD and HC (p = 0.795).</p><table-wrap id="pone.0164607.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0164607.t002</object-id><label>Table 2</label><caption><title>Behavioral data evoked by laser-induced pain stimulation.</title></caption><alternatives><graphic id="pone.0164607.t002g" xlink:href="pone.0164607.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="3" rowspan="1">VAS (cm)</th><th align="center" colspan="3" rowspan="1">SCR magnitude (z score)</th></tr><tr><th align="left" rowspan="1" colspan="1">target energy (mJ)</th><th align="left" rowspan="1" colspan="1">PD</th><th align="left" rowspan="1" colspan="1">HC</th><th align="left" rowspan="1" colspan="1">group effect</th><th align="left" rowspan="1" colspan="1">PD</th><th align="left" rowspan="1" colspan="1">HC</th><th align="left" rowspan="1" colspan="1">group effect</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">440 (= LPS)</td><td align="left" rowspan="1" colspan="1">0.41 &#x000b1; 0.84</td><td align="left" rowspan="1" colspan="1">0.34 &#x000b1; 0.33</td><td align="left" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">-0.88 &#x000b1; 0.30</td><td align="left" rowspan="1" colspan="1">-0.64 &#x000b1; 0.92</td><td align="left" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">480</td><td align="left" rowspan="1" colspan="1">0.68 &#x000b1; 0.95</td><td align="left" rowspan="1" colspan="1">0.58 &#x000b1; 0.51</td><td align="left" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">-0.50 &#x000b1; 0.85</td><td align="left" rowspan="1" colspan="1">-0.60 &#x000b1; 0.49</td><td align="left" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">520</td><td align="left" rowspan="1" colspan="1">1.12 &#x000b1; 1.30</td><td align="left" rowspan="1" colspan="1">0.94 &#x000b1; 0.82</td><td align="left" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">-0.49 &#x000b1; 0.53</td><td align="left" rowspan="1" colspan="1">-0.42 &#x000b1; 0.61</td><td align="left" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">560</td><td align="left" rowspan="1" colspan="1">1.68 &#x000b1; 1.68</td><td align="left" rowspan="1" colspan="1">1.51 &#x000b1; 1.37</td><td align="left" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">0.06 &#x000b1; 0.58</td><td align="left" rowspan="1" colspan="1">0.21 &#x000b1; 0.79</td><td align="left" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">600</td><td align="left" rowspan="1" colspan="1">2.27 &#x000b1; 1.89</td><td align="left" rowspan="1" colspan="1">2.10 &#x000b1; 1.82</td><td align="left" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">0.55 &#x000b1; 0.61</td><td align="left" rowspan="1" colspan="1">0.50 &#x000b1; 0.67</td><td align="left" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">640 (= HPS)</td><td align="left" rowspan="1" colspan="1">2.67 &#x000b1; 1.97</td><td align="left" rowspan="1" colspan="1">2.50 &#x000b1; 1.96</td><td align="left" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">1.25 &#x000b1; 0.49</td><td align="left" rowspan="1" colspan="1">0.95 &#x000b1; 0.76</td><td align="left" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">within group effect</td><td align="left" rowspan="1" colspan="1">&#x003c7;<sup>2</sup>(5) = 61.84, <bold>p &#x0003c; 0.001</bold></td><td align="left" rowspan="1" colspan="1">&#x003c7;<sup>2</sup>(5) = 49.64, <bold>p &#x0003c; 0.001</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">F(3,28) = 18.42, <bold>p &#x0003c; 0.001</bold></td><td align="left" rowspan="1" colspan="1">F(5,55) = 8.31, <bold>p &#x0003c; 0.001</bold></td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Data was collected immediately after the fMRI investigation.</p></fn><fn id="t002fn002"><p>HC: control subjects, HPS: high pain laser stimulus (E = 600 mJ), LPS: low pain laser stimulus (E = 440 mJ), PD: patients with early-stage Parkinson&#x02019;s disease (OFF state), SCR: skin conductance response, VAS: visual analogue scale.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec018"><title>Electrodermal responses</title><p>Electrodermal measurements did not result in significant group differences of standardized SCR magnitudes (<xref ref-type="table" rid="pone.0164607.t002">Table 2</xref>). The different target energies yielded significantly different standardized SCR magnitudes (<xref ref-type="table" rid="pone.0164607.t002">Table 2</xref>). In both groups, post hoc tests showed that HPS led to significant higher standardized SCR magnitudes than LPS (PD: p &#x0003c; 0.001; HC: p &#x0003c; 0.025). Target energy and standardized SCR magnitudes were significantly correlated (PD: r = 0.77, p &#x0003c; 0.001; HC: r = 0.64, p &#x0003c; 0.001) and showed a linear relationship (PD: r<sup>2</sup> = 0.59, y = -5.53 + 0.01x; HC: r<sup>2</sup> = 0.41, y = -4.59 + 8.5&#x000b7;10<sup>-3</sup>x). The correlation between target energy and SCR magnitudes was not significantly different between PD and HC (p = 0.125).</p></sec><sec id="sec019"><title>FMRI data</title><sec id="sec020"><title>Central pain activation in PD patients (OFF state) and in healthy controls</title><p>For LPS, PD patients showed significant activation (p &#x0003c; 0.05, FWE cluster corrected) in ipsilateral supplementary motor cortex (SMA), bilateral in parietal operculum/secondary somatosensory cortex (S2) (contralateral: OP1-4; ipsilateral: OP4) (LPS<sub>PD</sub> &#x0003e; baseline), mesial cingulate cortex (MCC), and contralateral insula (Ig1, Ig2) (<xref ref-type="fig" rid="pone.0164607.g002">Fig 2A</xref>, <xref ref-type="table" rid="pone.0164607.t003">Table 3</xref>). For LPS, control subjects showed significant activations (p &#x0003c; 0.05, FWE cluster corrected) in parietal operculum/S2 (contralateral: OP1, OP3, OP4; ipsilateral: OP1, OP3), inferior parietal cortex (contralateral: PFcm, PFop; ipsilateral: PFcm, PFop), and in primarily contralateral SMA (LPS<sub>HC</sub> &#x0003e; baseline) (<xref ref-type="fig" rid="pone.0164607.g002">Fig 2B</xref>, <xref ref-type="table" rid="pone.0164607.t004">Table 4</xref>).</p><fig id="pone.0164607.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0164607.g002</object-id><label>Fig 2</label><caption><title>Central activation for the LPS and HPS pain condition in early-stage PD and healthy controls.</title><p>Central activation (p &#x0003c; 0.05, FWE cluster corrected) in early-stage PD patients (A, C) and healthy controls (B, D) for the LPS (A, B) and HPS (C, D) condition. For activated regions see also <xref ref-type="table" rid="pone.0164607.t003">Table 3</xref> and <xref ref-type="table" rid="pone.0164607.t004">Table 4</xref>. HC: healthy controls, HPS: high pain laser stimulus with higher target energy (E = 600 mJ), LPS: low pain laser stimulus with lower target energy (E = 440 mJ), PD: patients with early-stage Parkinson&#x02019;s disease in OFF state.</p></caption><graphic xlink:href="pone.0164607.g002"/></fig><table-wrap id="pone.0164607.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0164607.t003</object-id><label>Table 3</label><caption><title>Main effects of laser pain stimulation in PD patients.</title></caption><alternatives><graphic id="pone.0164607.t003g" xlink:href="pone.0164607.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Cytoarchitectonic region</th><th align="left" rowspan="1" colspan="1">Side</th><th align="left" rowspan="1" colspan="1">K</th><th align="left" rowspan="1" colspan="1">T</th><th align="left" rowspan="1" colspan="1">Z</th><th align="left" rowspan="1" colspan="1">x</th><th align="left" rowspan="1" colspan="1">y</th><th align="left" rowspan="1" colspan="1">z</th></tr></thead><tbody><tr><td align="center" colspan="8" rowspan="1"><bold>LPS</bold><sub><bold>PD</bold></sub>
<bold>&#x0003e; baseline</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Mesial cingulate cortex</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">207</td><td align="left" rowspan="1" colspan="1">6.06</td><td align="left" rowspan="1" colspan="1">4.02</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">46</td></tr><tr><td align="left" rowspan="1" colspan="1">Mesial cingulate cortex</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5.36</td><td align="left" rowspan="1" colspan="1">3.76</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">37</td></tr><tr><td align="left" rowspan="1" colspan="1">Supplementary motor area</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5.03</td><td align="left" rowspan="1" colspan="1">3.62</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">55</td></tr><tr><td align="left" rowspan="1" colspan="1">Insula lobe (OP2)</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">116</td><td align="left" rowspan="1" colspan="1">5.10</td><td align="left" rowspan="1" colspan="1">3.65</td><td align="left" rowspan="1" colspan="1">-33</td><td align="left" rowspan="1" colspan="1">-22</td><td align="left" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="1" colspan="1">Rolandic operculum (OP4)</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5.07</td><td align="left" rowspan="1" colspan="1">3.64</td><td align="left" rowspan="1" colspan="1">-51</td><td align="left" rowspan="1" colspan="1">-1</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">Insula lobe</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.50</td><td align="left" rowspan="1" colspan="1">3.38</td><td align="left" rowspan="1" colspan="1">-39</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">Rolandic operculum (OP4)</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">99</td><td align="left" rowspan="1" colspan="1">5.07</td><td align="left" rowspan="1" colspan="1">3.64</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">-1</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">Inferior frontal gyrus (p. opercularis)</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.71</td><td align="left" rowspan="1" colspan="1">3.48</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="1" colspan="1">Insula lobe, OP3</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.54</td><td align="left" rowspan="1" colspan="1">3.40</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">-1</td><td align="left" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">Insula lobe</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">87</td><td align="left" rowspan="1" colspan="1">6.91</td><td align="left" rowspan="1" colspan="1">4.31</td><td align="left" rowspan="1" colspan="1">-30</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Rolandic operculum</italic></td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">73</td><td align="left" rowspan="1" colspan="1">5.32</td><td align="left" rowspan="1" colspan="1">3.74</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">-19</td><td align="left" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Rolandic operculum (OP1)</italic></td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.67</td><td align="left" rowspan="1" colspan="1">3.46</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">-19</td><td align="left" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Supramarginal gyrus</italic>, <italic>PFop (IPL)</italic></td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.49</td><td align="left" rowspan="1" colspan="1">3.37</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">-28</td><td align="left" rowspan="1" colspan="1">25</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Postcentral gyrus</italic>, <italic>PFop (IPL)</italic></td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">59</td><td align="left" rowspan="1" colspan="1">4.73</td><td align="left" rowspan="1" colspan="1">3.49</td><td align="left" rowspan="1" colspan="1">-63</td><td align="left" rowspan="1" colspan="1">-22</td><td align="left" rowspan="1" colspan="1">19</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Supramarginal gyrus</italic>, <italic>PFop (IPL)</italic></td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.52</td><td align="left" rowspan="1" colspan="1">3.39</td><td align="left" rowspan="1" colspan="1">-60</td><td align="left" rowspan="1" colspan="1">-28</td><td align="left" rowspan="1" colspan="1">28</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Superior temporal gyrus</italic>, <italic>PFcm (IPL)</italic></td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.30</td><td align="left" rowspan="1" colspan="1">3.28</td><td align="left" rowspan="1" colspan="1">-54</td><td align="left" rowspan="1" colspan="1">-34</td><td align="left" rowspan="1" colspan="1">13</td></tr><tr><td align="center" colspan="8" rowspan="1"><bold>HPS</bold><sub><bold>PD</bold></sub>
<bold>&#x0003e; baseline</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Insula lobe, OP2</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">1667</td><td align="left" rowspan="1" colspan="1">11.31</td><td align="left" rowspan="1" colspan="1">5.34</td><td align="left" rowspan="1" colspan="1">-33</td><td align="left" rowspan="1" colspan="1">-19</td><td align="left" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="1" colspan="1">Thalamus, parietal</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">9.04</td><td align="left" rowspan="1" colspan="1">4.88</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">-25</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">OP1</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">8.76</td><td align="left" rowspan="1" colspan="1">4.82</td><td align="left" rowspan="1" colspan="1">-45</td><td align="left" rowspan="1" colspan="1">-19</td><td align="left" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">Insula, Id1</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">837</td><td align="left" rowspan="1" colspan="1">9.04</td><td align="left" rowspan="1" colspan="1">4.88</td><td align="left" rowspan="1" colspan="1">42</td><td align="left" rowspan="1" colspan="1">-1</td><td align="left" rowspan="1" colspan="1">-17</td></tr><tr><td align="left" rowspan="1" colspan="1">Rolandic operculum, Pfop (IPL)</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">8.36</td><td align="left" rowspan="1" colspan="1">4.72</td><td align="left" rowspan="1" colspan="1">57</td><td align="left" rowspan="1" colspan="1">-16</td><td align="left" rowspan="1" colspan="1">19</td></tr><tr><td align="left" rowspan="1" colspan="1">Insula lobe, Ig2</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6.96</td><td align="left" rowspan="1" colspan="1">4.33</td><td align="left" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">-13</td><td align="left" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">Mesial cingulate cortex</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">522</td><td align="left" rowspan="1" colspan="1">7.24</td><td align="left" rowspan="1" colspan="1">4.41</td><td align="left" rowspan="1" colspan="1">-6</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">40</td></tr><tr><td align="left" rowspan="1" colspan="1">Mesial cingulate cortex</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6.47</td><td align="left" rowspan="1" colspan="1">4.17</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">43</td></tr><tr><td align="left" rowspan="1" colspan="1">Anterior cingulate cortex</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6.46</td><td align="left" rowspan="1" colspan="1">4.17</td><td align="left" rowspan="1" colspan="1">-3</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">31</td></tr><tr><td align="left" rowspan="1" colspan="1">Precuneus, 5m (SPL)</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">392</td><td align="left" rowspan="1" colspan="1">7.42</td><td align="left" rowspan="1" colspan="1">4.46</td><td align="left" rowspan="1" colspan="1">-6</td><td align="left" rowspan="1" colspan="1">-49</td><td align="left" rowspan="1" colspan="1">61</td></tr><tr><td align="left" rowspan="1" colspan="1">Precuneus, 5l (SPL)</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">7.32</td><td align="left" rowspan="1" colspan="1">4.43</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">-52</td><td align="left" rowspan="1" colspan="1">64</td></tr><tr><td align="left" rowspan="1" colspan="1">Superior parietal lobule, 5l (SPL)</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">7.21</td><td align="left" rowspan="1" colspan="1">4.40</td><td align="left" rowspan="1" colspan="1">-18</td><td align="left" rowspan="1" colspan="1">-43</td><td align="left" rowspan="1" colspan="1">64</td></tr><tr><td align="left" rowspan="1" colspan="1">Posterior cingulate cortex</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">57</td><td align="left" rowspan="1" colspan="1">6.19</td><td align="left" rowspan="1" colspan="1">4.07</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">-31</td><td align="left" rowspan="1" colspan="1">25</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Maxima of activation clusters for the LPS and HPS condition in patients with early-stage Parkinson&#x02019;s disease (PD, OFF state). Statistical threshold: p &#x0003c; 0.05, FWE cluster corrected; italic: trend activation at p &#x0003c; 0.001, uncorrected (extent threshold 59 vx).</p></fn><fn id="t003fn002"><p>HPS: high pain laser stimulus (target energy E = 600 mJ), IPL: inferior parietal lobule, K: cluster size, L: left, LPS: low pain laser stimulus (target energy E = 440 mJ), OP: parietal operculum, R: right, SPL: superior parietal lobule, T: T values, X/Y/Z: coordinates in MNI space, Z: Z scores.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone.0164607.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0164607.t004</object-id><label>Table 4</label><caption><title>Main effects of laser pain stimulation in healthy control subjects.</title></caption><alternatives><graphic id="pone.0164607.t004g" xlink:href="pone.0164607.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Cytoarchitectonic region</th><th align="left" rowspan="1" colspan="1">Side</th><th align="left" rowspan="1" colspan="1">K</th><th align="left" rowspan="1" colspan="1">T</th><th align="left" rowspan="1" colspan="1">Z</th><th align="left" rowspan="1" colspan="1">x</th><th align="left" rowspan="1" colspan="1">y</th><th align="left" rowspan="1" colspan="1">z</th></tr></thead><tbody><tr><td align="center" colspan="8" rowspan="1"><bold>LPS</bold><sub><bold>HC</bold></sub>
<bold>&#x0003e; baseline</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Superior temporal gyrus, PF (IPL)</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">134</td><td align="left" rowspan="1" colspan="1">6.21</td><td align="left" rowspan="1" colspan="1">4.08</td><td align="left" rowspan="1" colspan="1">-63</td><td align="left" rowspan="1" colspan="1">-31</td><td align="left" rowspan="1" colspan="1">19</td></tr><tr><td align="left" rowspan="1" colspan="1">Superior temporal gyrus, OP1</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5.89</td><td align="left" rowspan="1" colspan="1">3.97</td><td align="left" rowspan="1" colspan="1">-48</td><td align="left" rowspan="1" colspan="1">-31</td><td align="left" rowspan="1" colspan="1">19</td></tr><tr><td align="left" rowspan="1" colspan="1">Postcentral gyrus, OP1</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5.02</td><td align="left" rowspan="1" colspan="1">3.62</td><td align="left" rowspan="1" colspan="1">-51</td><td align="left" rowspan="1" colspan="1">-19</td><td align="left" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1">Rolandic operculum, PFop (IPL)</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">113</td><td align="left" rowspan="1" colspan="1">6.94</td><td align="left" rowspan="1" colspan="1">4.32</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">-28</td><td align="left" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1">Superior temporal gyrus, PFcm (IPL)</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5.11</td><td align="left" rowspan="1" colspan="1">3.65</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">-37</td><td align="left" rowspan="1" colspan="1">19</td></tr><tr><td align="left" rowspan="1" colspan="1">Supramarginal gyrus, PFt (IPL)</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.67</td><td align="left" rowspan="1" colspan="1">3.46</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">-19</td><td align="left" rowspan="1" colspan="1">25</td></tr><tr><td align="left" rowspan="1" colspan="1">Superior frontal gyrus</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">97</td><td align="left" rowspan="1" colspan="1">6.21</td><td align="left" rowspan="1" colspan="1">4.08</td><td align="left" rowspan="1" colspan="1">-21</td><td align="left" rowspan="1" colspan="1">-10</td><td align="left" rowspan="1" colspan="1">61</td></tr><tr><td align="left" rowspan="1" colspan="1">Paracentral lobule</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6.01</td><td align="left" rowspan="1" colspan="1">4.01</td><td align="left" rowspan="1" colspan="1">-12</td><td align="left" rowspan="1" colspan="1">-16</td><td align="left" rowspan="1" colspan="1">70</td></tr><tr><td align="center" colspan="8" rowspan="1"><bold>HPS</bold><sub><bold>HC</bold></sub>
<bold>&#x0003e; baseline</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Insula lobe, OP2</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">356</td><td align="left" rowspan="1" colspan="1">10.05</td><td align="left" rowspan="1" colspan="1">5.10</td><td align="left" rowspan="1" colspan="1">-33</td><td align="left" rowspan="1" colspan="1">-19</td><td align="left" rowspan="1" colspan="1">19</td></tr><tr><td align="left" rowspan="1" colspan="1">Postcentral gyrus, PFt (IPL)</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6.61</td><td align="left" rowspan="1" colspan="1">4.21</td><td align="left" rowspan="1" colspan="1">-57</td><td align="left" rowspan="1" colspan="1">-22</td><td align="left" rowspan="1" colspan="1">31</td></tr><tr><td align="left" rowspan="1" colspan="1">Superior temporal gyrus, OP1</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6.42</td><td align="left" rowspan="1" colspan="1">4.15</td><td align="left" rowspan="1" colspan="1">-54</td><td align="left" rowspan="1" colspan="1">-28</td><td align="left" rowspan="1" colspan="1">19</td></tr><tr><td align="left" rowspan="1" colspan="1">Rolandic operculum, OP1</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">202</td><td align="left" rowspan="1" colspan="1">6.97</td><td align="left" rowspan="1" colspan="1">4.33</td><td align="left" rowspan="1" colspan="1">57</td><td align="left" rowspan="1" colspan="1">-19</td><td align="left" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="1" colspan="1">Rolandic operculum, PFcm</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6.16</td><td align="left" rowspan="1" colspan="1">4.06</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">-31</td><td align="left" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1">Superior temporal gyrus, PFm</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6.14</td><td align="left" rowspan="1" colspan="1">4.05</td><td align="left" rowspan="1" colspan="1">57</td><td align="left" rowspan="1" colspan="1">-43</td><td align="left" rowspan="1" colspan="1">19</td></tr><tr><td align="left" rowspan="1" colspan="1">Supplementary motor area</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">169</td><td align="left" rowspan="1" colspan="1">8.41</td><td align="left" rowspan="1" colspan="1">4.73</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">-7</td><td align="left" rowspan="1" colspan="1">67</td></tr><tr><td align="left" rowspan="1" colspan="1">Supplementary motor area</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6.88</td><td align="left" rowspan="1" colspan="1">4.30</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">-13</td><td align="left" rowspan="1" colspan="1">67</td></tr><tr><td align="left" rowspan="1" colspan="1">Supplementary motor area</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5.15</td><td align="left" rowspan="1" colspan="1">3.67</td><td align="left" rowspan="1" colspan="1">-15</td><td align="left" rowspan="1" colspan="1">-7</td><td align="left" rowspan="1" colspan="1">67</td></tr><tr><td align="left" rowspan="1" colspan="1">Rolandic operculum</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">149</td><td align="left" rowspan="1" colspan="1">5.86</td><td align="left" rowspan="1" colspan="1">3.95</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">Inferior frontal gyrus (p. Opercularis)</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5.52</td><td align="left" rowspan="1" colspan="1">3.82</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Insula lobe</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.53</td><td align="left" rowspan="1" colspan="1">3.39</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">Temporal pole</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">114</td><td align="left" rowspan="1" colspan="1">6.43</td><td align="left" rowspan="1" colspan="1">4.16</td><td align="left" rowspan="1" colspan="1">-39</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">-14</td></tr><tr><td align="left" rowspan="1" colspan="1">Insula lobe</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6.12</td><td align="left" rowspan="1" colspan="1">4.05</td><td align="left" rowspan="1" colspan="1">-39</td><td align="left" rowspan="1" colspan="1">-1</td><td align="left" rowspan="1" colspan="1">-5</td></tr><tr><td align="left" rowspan="1" colspan="1">Insula lobe</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.82</td><td align="left" rowspan="1" colspan="1">3.53</td><td align="left" rowspan="1" colspan="1">-33</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">Mesial cingulate cortex</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">66</td><td align="left" rowspan="1" colspan="1">5.25</td><td align="left" rowspan="1" colspan="1">3.71</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">40</td></tr><tr><td align="left" rowspan="1" colspan="1">Mesial cingulate cortex</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.70</td><td align="left" rowspan="1" colspan="1">3.47</td><td align="left" rowspan="1" colspan="1">-6</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">46</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>Maxima of activation clusters for the LPS and HPS condition in healthy control subjects (HC). Statistical threshold: p &#x0003c; 0.05, FWE cluster corrected.</p></fn><fn id="t004fn002"><p>HPS: high pain laser stimulus with higher target energy (E = 600 mJ), IPL: inferior parietal lobule, K: cluster size, L: left, LPS: low pain laser stimulus with lower target energy (E = 440 mJ), OP: parietal operculum, R: right, T: T values, X/Y/Z: coordinates in MNI space, Z: Z scores.</p></fn></table-wrap-foot></table-wrap><p>For HPS, PD patients showed significant activations (p &#x0003c; 0.05, FWE cluster corrected) in parietal inferior lobule (PFcm, PFm, PFop, PFt), parietal operculum/S2 (OP1-4), SMA, mesial cingulate cortex, and in the insula (contralateral: Ig2, Id; ipsilateral: Ig1, Ig2, Id1) (HPS<sub>PD</sub> &#x0003e; baseline). Additional bilateral activation was observed in superior parietal lobule/precuneus (5m, 5l, 5Ci), anterior and posterior cingulate cortex (ACC, PCC), and in thalamus (<xref ref-type="fig" rid="pone.0164607.g002">Fig 2C</xref>, <xref ref-type="table" rid="pone.0164607.t003">Table 3</xref>). For HPS, control subjects showed significant bilateral activation (p &#x0003c; 0.05, FWE cluster corrected) in parietal operculum/S2 (contralateral: OP1-4; ipsilateral: OP1, OP4), inferior parietal cortex (contralateral: PFcm, PFop, PFt; ipsilateral: PFcm, PFm, PFop, PFt), SMA, and insula (Ig1, Ig2) (<xref ref-type="fig" rid="pone.0164607.g002">Fig 2D</xref>, <xref ref-type="table" rid="pone.0164607.t004">Table 4</xref>).</p></sec><sec id="sec021"><title>Between group comparison: PD patients (OFF state) vs. healthy controls</title><p>For LPS, the between group comparison of activation in PD patients and healthy controls (contrasts: LPS<sub>PD</sub> &#x0003e; LPS<sub>HC</sub>, LPS<sub>HC</sub> &#x0003e; LPS<sub>PD</sub>) did not reveal any significant differences. On the contrary, the between group comparison for HPS (contrasts: HPS<sub>PD</sub> &#x0003e; HPS<sub>HC</sub>, HPS<sub>HC</sub> &#x0003e; HPS<sub>PD</sub>) showed increased activations (p &#x0003c; 0.05, FWE cluster corrected) in precuneus and PCC in PD patients (<xref ref-type="fig" rid="pone.0164607.g003">Fig 3</xref>, <xref ref-type="table" rid="pone.0164607.t005">Table 5</xref>). For visualization purposes and to demonstrate the full extent of the activation differences, the statistical threshold was reduced to p &#x0003c; 0.001, uncorrected, showing also a tendency for increased activations in ipsilateral medial frontal gyrus and thalamus bilaterally. Hence, relatively increased activations in PD were localized in regions of the default mode network (DMN), containing medial prefrontal cortex (mPFC), PCC, precuneus, lateral parietal cortex and medial temporal cortex [<xref rid="pone.0164607.ref055" ref-type="bibr">55</xref>,<xref rid="pone.0164607.ref056" ref-type="bibr">56</xref>]. To test whether these effects were driven by BDI or STAI-state values, a regression analysis was performed in the PD group (p &#x0003c; 0.001, uncorrected). This analysis found no indication that the precuneus/PCC activation is driven by the covariates BDI plus STAI-state.</p><fig id="pone.0164607.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0164607.g003</object-id><label>Fig 3</label><caption><title>Increased central activation in early-staged PD patients vs. healthy controls for the HPS condition.</title><p>Increased central activation (p &#x0003c; 0.05, FWE cluster corrected) for the high laser pain condition (HPS, target energy E = 600 mJ) in patients with early-staged Parkinson&#x02019;s disease (PD, OFF state) vs. healthy control subjects (HC) in posterior cingulate cortex (A) and precuneus (B). Trend activation (p &#x0003c; 0.001, uncorrected) in ipsilateral medial frontal gyrus (C) and bilateral thalamus (D).</p></caption><graphic xlink:href="pone.0164607.g003"/></fig><table-wrap id="pone.0164607.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0164607.t005</object-id><label>Table 5</label><caption><title>Between group effects (PD vs. HC) for the HPS condition.</title></caption><alternatives><graphic id="pone.0164607.t005g" xlink:href="pone.0164607.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Cytoarchitectonic region</th><th align="left" rowspan="1" colspan="1">Side</th><th align="left" rowspan="1" colspan="1">K</th><th align="left" rowspan="1" colspan="1">T</th><th align="left" rowspan="1" colspan="1">Z</th><th align="left" rowspan="1" colspan="1">x</th><th align="left" rowspan="1" colspan="1">y</th><th align="left" rowspan="1" colspan="1">z</th></tr><tr><th align="center" colspan="8" rowspan="1">Between group effects HPS<sub>PD</sub> &#x0003e; HPS<sub>HC</sub></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Precuneus</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">97</td><td align="left" rowspan="1" colspan="1">4.86</td><td align="left" rowspan="1" colspan="1">4.01</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">-52</td><td align="left" rowspan="1" colspan="1">46</td></tr><tr><td align="left" rowspan="1" colspan="1">Precuneus</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.94</td><td align="left" rowspan="1" colspan="1">3.43</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">-70</td><td align="left" rowspan="1" colspan="1">37</td></tr><tr><td align="left" rowspan="1" colspan="1">Precuneus, 5m (SPL)</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">92</td><td align="left" rowspan="1" colspan="1">4.67</td><td align="left" rowspan="1" colspan="1">3.90</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">-49</td><td align="left" rowspan="1" colspan="1">61</td></tr><tr><td align="left" rowspan="1" colspan="1">Precuneus</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.78</td><td align="left" rowspan="1" colspan="1">3.32</td><td align="left" rowspan="1" colspan="1">-6</td><td align="left" rowspan="1" colspan="1">-55</td><td align="left" rowspan="1" colspan="1">43</td></tr><tr><td align="left" rowspan="1" colspan="1">5Ci (SPL)</td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.76</td><td align="left" rowspan="1" colspan="1">3.30</td><td align="left" rowspan="1" colspan="1">-15</td><td align="left" rowspan="1" colspan="1">-46</td><td align="left" rowspan="1" colspan="1">46</td></tr><tr><td align="left" rowspan="1" colspan="1">Posterior cingulate cortex</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">91</td><td align="left" rowspan="1" colspan="1">5.72</td><td align="left" rowspan="1" colspan="1">4.50</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">-31</td><td align="left" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1">Precuneus</td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.03</td><td align="left" rowspan="1" colspan="1">3.49</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">-46</td><td align="left" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Medial frontal gyrus</italic></td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">4.65</td><td align="left" rowspan="1" colspan="1">3.89</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1">28</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Thalamus</italic>, <italic>parietal</italic></td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">4.40</td><td align="left" rowspan="1" colspan="1">3.73</td><td align="left" rowspan="1" colspan="1">-15</td><td align="left" rowspan="1" colspan="1">-25</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Thalamus</italic>, <italic>temporal</italic></td><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.19</td><td align="left" rowspan="1" colspan="1">3.59</td><td align="left" rowspan="1" colspan="1">-9</td><td align="left" rowspan="1" colspan="1">-25</td><td align="left" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Thalamus</italic>, <italic>parietal</italic></td><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1">4.79</td><td align="left" rowspan="1" colspan="1">3.97</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">-28</td><td align="left" rowspan="1" colspan="1">7</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p>Maxima of activation clusters for the HPS condition in patients with early-staged Parkinson&#x02019;s disease (PD, OFF state) vs. healthy control subjects (HC). Statistical threshold: p &#x0003c; 0.05, FWE cluster corrected; italic: trend activation at p &#x0003c; 0.001, uncorrected (extent threshold 38 vx). HC: control subjects, HPS: high pain laser stimulus with higher target energy (E = 600 mJ), K: cluster size, L: left, LPS: low pain laser stimulus with lower target energy (E = 440 mJ), R: right, SPL: superior parietal lobule, T: T values, X/Y/Z: coordinates in MNI space, Z: Z scores.</p></fn></table-wrap-foot></table-wrap></sec></sec></sec><sec sec-type="conclusions" id="sec022"><title>Discussion</title><p>This is the first study investigating central pain perception in PD using a multimodal experimental approach, notably at behavioral, autonomic, and imaging levels. No significant differences in WPT, HPT, EDA and subjective pain ratings were found between early-stage PD patients and controls, and erfMRI revealed a generally comparable activation pattern in brain areas belonging to the central pain matrix. Relatively reduced deactivation was found in PD in posterior regions of the DMN, notably the precuneus and the posterior cingulate cortex. In the following the results are discussed at the peripheral and central levels.</p><sec id="sec023"><title>Peripheral pain perception in PD</title><p>When investigating pain discrimination in PD, careful clinical assessments are essential to account for the elevated prevalence of pain [<xref rid="pone.0164607.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0164607.ref057" ref-type="bibr">57</xref>,<xref rid="pone.0164607.ref058" ref-type="bibr">58</xref>], and the association of chronic pain, depression and anxiety disorders in PD [<xref rid="pone.0164607.ref059" ref-type="bibr">59</xref>&#x02013;<xref rid="pone.0164607.ref063" ref-type="bibr">63</xref>]. Therefore, we enrolled exclusively PD patients without chronic pain or psychiatric diseases, minimizing secondary effects on pain perception. Although our PD patients showed higher BDI scores and state anxiety values, we didn&#x02019;t observe significant group differences concerning warmth perception thresholds, heat pain thresholds, laser-induced pain perception or electrodermal measurements. Thus, we assume a negligible effect of these parameters on sensory discriminative levels of pain perception.</p><p>Compared to HC, our behavioral investigations revealed unaltered warmth and thermal heat pain thresholds, and comparable laser-induced cutaneous pain perception in early-stage PD patients tested in the OFF state. We thus assume comparable peripheral sensory and nociceptive transmission, a claim further strengthened by electrophysiological exclusion of peripheral neuropathy. Thus, while our results support former reports of unaltered warmth perception thresholds in PD [<xref rid="pone.0164607.ref064" ref-type="bibr">64</xref>], we couldn&#x02019;t confirm previous work reporting decreased pain thresholds [<xref rid="pone.0164607.ref035" ref-type="bibr">35</xref>,<xref rid="pone.0164607.ref064" ref-type="bibr">64</xref>&#x02013;<xref rid="pone.0164607.ref067" ref-type="bibr">67</xref>] and, thus, found no support for a modified sensory discriminative pain perception in early-stage PD. Indeed, the literature on altered sensory discriminative pain perception is highly inconsistent [<xref rid="pone.0164607.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0164607.ref068" ref-type="bibr">68</xref>,<xref rid="pone.0164607.ref069" ref-type="bibr">69</xref>]. This might be explained to some extent by patient selection differences (e.g. disease stage, presence of chronic pain, pharmacological treatment, etc.). For instance, associations between decreased pain thresholds and severity of motor symptoms indicate that pain in PD might be triggered by rigidity or bradykinesia [<xref rid="pone.0164607.ref066" ref-type="bibr">66</xref>]. In addition, neuropathological deficits at the level of peripheral nerves could have affected pain perception, as the presence of peripheral sensory dysfunction wasn&#x02019;t systematically ruled out in all of the mentioned studies. Finally, variable test methods including a wide range of stimulus modalities (e.g. thermic, electric, or laser-induced), stimulus localizations (e.g. upper vs. lower extremities) and stimulus durations (&#x0003c; 1 ms to 90 s) might explain the mentioned inconsistencies in the literature.</p><p>Our electrodermal measurements during laser-induced pain also didn&#x02019;t reveal any significant group differences, suggesting unaltered autonomic response to nociception in early-stage PD patients.</p></sec><sec id="sec024"><title>Central pain activation in PD</title><p>Laser-induced nociceptive stimulation induced a pain-specific activation pattern encompassing regions of the central pain matrix (CPM) [<xref rid="pone.0164607.ref070" ref-type="bibr">70</xref>&#x02013;<xref rid="pone.0164607.ref074" ref-type="bibr">74</xref>], including secondary somatosensory cortex (S2), insula, cingulate cortex and thalamus, both in PD patients and healthy controls. Besides group difference found in DMN regions, no significant group differences were observed within regions of the CPM, either in HPS or LPS pain conditions. This suggests a comparable recruitment of areas involved in sensory discriminative or affective nociceptive processing like SII [<xref rid="pone.0164607.ref050" ref-type="bibr">50</xref>,<xref rid="pone.0164607.ref073" ref-type="bibr">73</xref>,<xref rid="pone.0164607.ref075" ref-type="bibr">75</xref>,<xref rid="pone.0164607.ref076" ref-type="bibr">76</xref>] and the insula [<xref rid="pone.0164607.ref070" ref-type="bibr">70</xref>,<xref rid="pone.0164607.ref072" ref-type="bibr">72</xref>,<xref rid="pone.0164607.ref073" ref-type="bibr">73</xref>,<xref rid="pone.0164607.ref077" ref-type="bibr">77</xref>] in early-stage PD patients and controls. This finding is contrary to our study hypothesis, influenced by the hitherto only imaging study examining central pain processing in PD [<xref rid="pone.0164607.ref035" ref-type="bibr">35</xref>]. Brefel-Courbon et al. reported increased activation in PD in regions involved in affective nociceptive processing (i.e. ipsilateral posterior insula, prefrontal cortex, contralateral ACC). Although these PD patients were in a more advanced clinical stage (Hoehn and Yahr stage 2.2 vs.1.27), the validity and reproducibility of these results at a very liberal statistical threshold has to be questioned [<xref rid="pone.0164607.ref035" ref-type="bibr">35</xref>]. Moreover, no systematic screening for peripheral sensory dysfunction was performed [<xref rid="pone.0164607.ref036" ref-type="bibr">36</xref>], or for neuropsychological factors affecting pain sensation (e.g. depressive symptoms, situational anxiety).</p></sec><sec id="sec025"><title>Default mode network in PD</title><p>Relative increases of HPS-induced activation were observed in precuneus and PCC in the PD group. The changes reflect decreased deactivation in the PD group, as compared to HC and reinforce former imaging data showing abnormal processing of external stimuli and increased activity (resp. decreased deactivation) of the DMN in PD patients [<xref rid="pone.0164607.ref078" ref-type="bibr">78</xref>,<xref rid="pone.0164607.ref079" ref-type="bibr">79</xref>]. To our knowledge, this is the first study showing DMN dysfunction in PD patients during nociceptive processing. As both covariates did not correlate with the precuneus and PCC activation in the PD cohort, it is rather unlikely that the observed DMN effects are driven by mood or anxiety levels. Alterations of DMN activity and connectivity have also been described in states of altered cognitive processing, both in physiological aging and neurodegenerative diseases [<xref rid="pone.0164607.ref080" ref-type="bibr">80</xref>,<xref rid="pone.0164607.ref081" ref-type="bibr">81</xref>]. DMN dysfunction has been reported also in neuropsychiatric disorders like autism, schizophrenia, Alzheimer&#x02019;s disease and depression [<xref rid="pone.0164607.ref082" ref-type="bibr">82</xref>,<xref rid="pone.0164607.ref083" ref-type="bibr">83</xref>].</p></sec><sec id="sec026"><title>Limitations</title><p>A limiting factor of our study is the small sample size of subjects which is mainly a consequence of adherence to strict exclusion / inclusion criteria, notably using electrophysiological testing to rule out individuals with evidence of peripheral neuropathy which may influence conductance of nociceptive stimuli and affect central pain-related activation patterns. We chose these criteria for the benefit of high-quality data in homogeneous collectives with highly diminished confounding effects on pain perception.</p></sec></sec><sec sec-type="conclusions" id="sec027"><title>Conclusion</title><p>Early-stage PD patients show abnormalities of DMN function during nociceptive processing, extending previous findings in other behavioral domains. Experimental correlates of nociceptive processing, as tested at behavioral, autonomic, imaging levels, revealed no genuine pain-specific processing abnormality in early-stage PD, after exclusion of peripheral neuropathy using electrophysiological screening. Applying similar rigorous methodological approaches, future studies are now required to examine pain processing in more advanced stages of PD.</p></sec></body><back><ref-list><title>References</title><ref id="pone.0164607.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Rodriguez-Oroz</surname><given-names>MC</given-names></name>, <name><surname>Jahanshahi</surname><given-names>M</given-names></name>, <name><surname>Krack</surname><given-names>P</given-names></name>, <name><surname>Litvan</surname><given-names>I</given-names></name>, <name><surname>Macias</surname><given-names>R</given-names></name>, <name><surname>Bezard</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Initial clinical manifestations of Parkinson&#x02019;s disease: features and pathophysiological mechanisms</article-title>. <source>Lancet Neurol</source>. <year>2009</year>;<volume>8</volume>: <fpage>1128</fpage>&#x02013;<lpage>1139</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1474-4422(09)70293-5">10.1016/S1474-4422(09)70293-5</ext-link></comment>
<pub-id pub-id-type="pmid">19909911</pub-id></mixed-citation></ref><ref id="pone.0164607.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Lima</surname><given-names>MM</given-names></name>, <name><surname>Martins</surname><given-names>EF</given-names></name>, <name><surname>Delattre</surname><given-names>AM</given-names></name>, <name><surname>Proenca</surname><given-names>MB</given-names></name>, <name><surname>Mori</surname><given-names>MA</given-names></name>, <name><surname>Carabelli</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Motor and non-motor features of Parkinson&#x02019;s disease&#x02014;a review of clinical and experimental studies</article-title>. <source>CNS Neurol Disord Drug Targets</source>. <year>2012</year>;<volume>11</volume>: <fpage>439</fpage>&#x02013;<lpage>449</lpage>. <pub-id pub-id-type="pmid">22483309</pub-id></mixed-citation></ref><ref id="pone.0164607.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Bernal-Pacheco</surname><given-names>O</given-names></name>, <name><surname>Limotai</surname><given-names>N</given-names></name>, <name><surname>Go</surname><given-names>CL</given-names></name>, <name><surname>Fernandez</surname><given-names>HH</given-names></name>. <article-title>Nonmotor Manifestations in Parkinson Disease</article-title>. <source>Neurologist</source>. <year>2012</year>;<volume>18</volume>: <fpage>1</fpage>&#x02013;<lpage>16</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/NRL.0b013e31823d7abb">10.1097/NRL.0b013e31823d7abb</ext-link></comment>
<pub-id pub-id-type="pmid">22217609</pub-id></mixed-citation></ref><ref id="pone.0164607.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Garcia-Ruiz</surname><given-names>PJ</given-names></name>, <name><surname>Chaudhuri</surname><given-names>KR</given-names></name>, <name><surname>Martinez-Martin</surname><given-names>P</given-names></name>. <article-title>Non-motor symptoms of Parkinson&#x02019;s disease A review&#x02026;from the past</article-title>. <source>J Neurol Sci</source>. <year>2014</year>;<volume>338</volume>: <fpage>30</fpage>&#x02013;<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jns.2014.01.002">10.1016/j.jns.2014.01.002</ext-link></comment>
<pub-id pub-id-type="pmid">24433931</pub-id></mixed-citation></ref><ref id="pone.0164607.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Simuni</surname><given-names>T</given-names></name>, <name><surname>Sethi</surname><given-names>K</given-names></name>. <article-title>Nonmotor manifestations of Parkinson&#x02019;s disease</article-title>. <source>Ann Neurol</source>. <year>2009</year>;<volume>64</volume>: <fpage>65</fpage>&#x02013;<lpage>80</lpage>.</mixed-citation></ref><ref id="pone.0164607.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Martinez-Martin</surname><given-names>P</given-names></name>, <name><surname>Schapira AH</surname><given-names>V</given-names></name>, <name><surname>Stocchi</surname><given-names>F</given-names></name>, <name><surname>Sethi</surname><given-names>K</given-names></name>, <name><surname>Odin</surname><given-names>P</given-names></name>, <name><surname>MacPhee</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Prevalence of nonmotor symptoms in Parkinson&#x02019;s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients</article-title>. <source>Mov Disord</source>. <year>2007</year>;<volume>22</volume>: <fpage>1623</fpage>&#x02013;<lpage>1629</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/mds.21586">10.1002/mds.21586</ext-link></comment>
<pub-id pub-id-type="pmid">17546669</pub-id></mixed-citation></ref><ref id="pone.0164607.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Goldman</surname><given-names>JG</given-names></name>, <name><surname>Williams-Gray</surname><given-names>C</given-names></name>, <name><surname>Barker</surname><given-names>RA</given-names></name>, <name><surname>Duda</surname><given-names>JE</given-names></name>, <name><surname>Galvin</surname><given-names>JE</given-names></name>. <article-title>The spectrum of cognitive impairment in Lewy body diseases</article-title>. <source>Mov Disord</source>. <year>2014</year>;<volume>29</volume>: <fpage>608</fpage>&#x02013;<lpage>621</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/mds.25866">10.1002/mds.25866</ext-link></comment>
<pub-id pub-id-type="pmid">24757110</pub-id></mixed-citation></ref><ref id="pone.0164607.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Marsh</surname><given-names>L</given-names></name>. <article-title>Depression and Parkinson&#x02019;s disease: current knowledge</article-title>. <source>Curr Neurol Neurosci Rep</source>. <year>2013</year>;<volume>13</volume>: <fpage>409</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11910-013-0409-5">10.1007/s11910-013-0409-5</ext-link></comment>
<pub-id pub-id-type="pmid">24190780</pub-id></mixed-citation></ref><ref id="pone.0164607.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Chaudhuri</surname><given-names>KR</given-names></name>. <article-title>Autonomic dysfunction in movement disorders</article-title>. <source>Curr Opin Neurol</source>. <year>2001</year>;<volume>14</volume>: <fpage>505</fpage>&#x02013;<lpage>511</lpage>. <pub-id pub-id-type="pmid">11470968</pub-id></mixed-citation></ref><ref id="pone.0164607.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Breen</surname><given-names>DP</given-names></name>, <name><surname>Vuono</surname><given-names>R</given-names></name>, <name><surname>Nawarathna</surname><given-names>U</given-names></name>, <name><surname>Fisher</surname><given-names>K</given-names></name>, <name><surname>Shneerson</surname><given-names>JM</given-names></name>, <name><surname>Reddy</surname><given-names>AB</given-names></name>, <etal>et al</etal>
<article-title>Sleep and circadian rhythm regulation in early Parkinson disease</article-title>. <source>JAMA Neurol</source>. <year>2014</year>;<volume>71</volume>: <fpage>589</fpage>&#x02013;<lpage>595</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jamaneurol.2014.65">10.1001/jamaneurol.2014.65</ext-link></comment>
<pub-id pub-id-type="pmid">24687146</pub-id></mixed-citation></ref><ref id="pone.0164607.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Neikrug</surname><given-names>AB</given-names></name>, <name><surname>Avanzino</surname><given-names>JA</given-names></name>, <name><surname>Liu</surname><given-names>L</given-names></name>, <name><surname>Maglione</surname><given-names>JE</given-names></name>, <name><surname>Natarajan</surname><given-names>L</given-names></name>, <name><surname>Corey-Bloom</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Parkinson&#x02019;s disease and REM sleep behavior disorder result in increased non-motor symptoms</article-title>. <source>Sleep Med</source>. <year>2014</year>;<volume>15</volume>: <fpage>959</fpage>&#x02013;<lpage>966</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.sleep.2014.04.009">10.1016/j.sleep.2014.04.009</ext-link></comment>
<pub-id pub-id-type="pmid">24938585</pub-id></mixed-citation></ref><ref id="pone.0164607.ref012"><label>12</label><mixed-citation publication-type="book"><name><surname>Parkinson</surname><given-names>J</given-names></name>. <source>An essay on the shaking palsy</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Sherwood, Neely, and Jones</publisher-name>; <year>1817</year>.</mixed-citation></ref><ref id="pone.0164607.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Beiske</surname><given-names>AG</given-names></name>, <name><surname>Loge</surname><given-names>JH</given-names></name>, <name><surname>R&#x000f8;nningen</surname><given-names>A</given-names></name>, <name><surname>Svensson</surname><given-names>E</given-names></name>. <article-title>Pain in Parkinson&#x02019;s disease: Prevalence and characteristics</article-title>. <source>Pain</source>. <year>2009</year>;<volume>141</volume>: <fpage>173</fpage>&#x02013;<lpage>177</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.pain.2008.12.004">10.1016/j.pain.2008.12.004</ext-link></comment>
<pub-id pub-id-type="pmid">19100686</pub-id></mixed-citation></ref><ref id="pone.0164607.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Ford</surname><given-names>B</given-names></name>. <article-title>Pain in Parkinson&#x02019;s Disease</article-title>. <source>Clin Neurosci</source>. <year>1998</year>;<volume>5</volume>: <fpage>63</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="pmid">10785830</pub-id></mixed-citation></ref><ref id="pone.0164607.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Giuffrida</surname><given-names>R</given-names></name>, <name><surname>Vingerhoets</surname><given-names>FJG</given-names></name>, <name><surname>Bogousslavsky</surname><given-names>J</given-names></name>, <name><surname>Ghika</surname><given-names>J</given-names></name>. <article-title>Pain in Parkinson&#x02019;s disease</article-title>. <source>Rev Neurol (Paris)</source>. <year>2005</year>;<volume>161</volume>: <fpage>407</fpage>&#x02013;<lpage>418</lpage>.<pub-id pub-id-type="pmid">15924076</pub-id></mixed-citation></ref><ref id="pone.0164607.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Borsook</surname><given-names>D</given-names></name>. <article-title>Neurological diseases and pain</article-title>. <source>Brain</source>. <year>2012</year>;<volume>135</volume>: <fpage>320</fpage>&#x02013;<lpage>344</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/brain/awr271">10.1093/brain/awr271</ext-link></comment>
<pub-id pub-id-type="pmid">22067541</pub-id></mixed-citation></ref><ref id="pone.0164607.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>MA</given-names></name>, <name><surname>Walker</surname><given-names>RW</given-names></name>, <name><surname>Hildreth</surname><given-names>TJ</given-names></name>, <name><surname>Prentice</surname><given-names>WM</given-names></name>. <article-title>A Survey of Pain in Idiopathic Parkinson&#x02019;s Disease</article-title>. <source>J Pain Symptom Manage</source>. <year>2006</year>;<volume>32</volume>: <fpage>462</fpage>&#x02013;<lpage>469</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jpainsymman.2006.05.020">10.1016/j.jpainsymman.2006.05.020</ext-link></comment>
<pub-id pub-id-type="pmid">17085272</pub-id></mixed-citation></ref><ref id="pone.0164607.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>N&#x000e8;gre-Pag&#x000e8;s</surname><given-names>L</given-names></name>, <name><surname>Regragui</surname><given-names>W</given-names></name>, <name><surname>Bouhassira</surname><given-names>D</given-names></name>, <name><surname>Grandjean</surname><given-names>H</given-names></name>, <name><surname>Rascol</surname><given-names>O</given-names></name>. <article-title>Chronic pain in Parkinson&#x02019;s disease: The cross-sectional French DoPaMiP survey</article-title>. <source>Mov Disord</source>. <year>2008</year>;<volume>23</volume>: <fpage>1361</fpage>&#x02013;<lpage>1369</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/mds.22142">10.1002/mds.22142</ext-link></comment>
<pub-id pub-id-type="pmid">18546344</pub-id></mixed-citation></ref><ref id="pone.0164607.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Defazio</surname><given-names>G</given-names></name>, <name><surname>Berardelli</surname><given-names>A</given-names></name>, <name><surname>Fabbrini</surname><given-names>G</given-names></name>, <name><surname>Martino</surname><given-names>D</given-names></name>, <name><surname>Fincati</surname><given-names>E</given-names></name>, <name><surname>Fiaschi</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Pain as a Nonmotor Symptom of Parkinson Disease: Evidence From a Case-Control Study</article-title>. <source>Arch Neurol</source>. <year>2008</year>;<volume>65</volume>: <fpage>1191</fpage>&#x02013;<lpage>1194</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/archneurol.2008.2">10.1001/archneurol.2008.2</ext-link></comment>
<pub-id pub-id-type="pmid">18779422</pub-id></mixed-citation></ref><ref id="pone.0164607.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Rana</surname><given-names>AQ</given-names></name>, <name><surname>Kabir</surname><given-names>A</given-names></name>, <name><surname>Jesudasan</surname><given-names>M</given-names></name>, <name><surname>Siddiqui</surname><given-names>I</given-names></name>, <name><surname>Khondker</surname><given-names>S</given-names></name>. <article-title>Pain in Parkinson&#x02019;s disease: Analysis and literature review</article-title>. <source>Clin Neurol Neurosurg</source>. <year>2013</year>;<volume>115</volume>: <fpage>2313</fpage>&#x02013;<lpage>2317</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.clineuro.2013.08.022">10.1016/j.clineuro.2013.08.022</ext-link></comment>
<pub-id pub-id-type="pmid">24075714</pub-id></mixed-citation></ref><ref id="pone.0164607.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Souques</surname><given-names>M</given-names></name>. <article-title>Des douleurs dans la paralysie agitante</article-title>. <source>Rev Neurol (Paris)</source>. <year>1921</year>;<volume>37</volume>: <fpage>629</fpage>&#x02013;<lpage>633</lpage>.</mixed-citation></ref><ref id="pone.0164607.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Juri</surname><given-names>C</given-names></name>, <name><surname>Rodriguez-Oroz</surname><given-names>M</given-names></name>, <name><surname>Obeso</surname><given-names>J</given-names></name>. <article-title>The pathophysiological basis of sensory disturbances in Parkinson&#x02019;s disease</article-title>. <source>J Neurol Sci</source>. Elsevier B.V.; <year>2010</year>;<volume>289</volume>: <fpage>60</fpage>&#x02013;<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jns.2009.08.018">10.1016/j.jns.2009.08.018</ext-link></comment>
<pub-id pub-id-type="pmid">19758602</pub-id></mixed-citation></ref><ref id="pone.0164607.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Schestatsky</surname><given-names>P</given-names></name>, <name><surname>Kumru</surname><given-names>H</given-names></name>, <name><surname>Valls-Sol&#x000e9;</surname><given-names>J</given-names></name>, <name><surname>Valldeoriola</surname><given-names>F</given-names></name>, <name><surname>Marti</surname><given-names>MJ</given-names></name>, <name><surname>Tolosa</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Neurophysiologic study of central pain in patients with Parkinson disease</article-title>. <source>Neurology</source>. <year>2007</year>;<volume>69</volume>: <fpage>2162</fpage>&#x02013;<lpage>2169</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1212/01.wnl.0000295669.12443.d3">10.1212/01.wnl.0000295669.12443.d3</ext-link></comment>
<pub-id pub-id-type="pmid">18056580</pub-id></mixed-citation></ref><ref id="pone.0164607.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Rabinak</surname><given-names>CA</given-names></name>, <name><surname>Nirenberg</surname><given-names>MJ</given-names></name>. <article-title>Dopamine agonist withdrawal syndrome in Parkinson disease</article-title>. <source>Arch Neurol</source>. <year>2010</year>;<volume>67</volume>: <fpage>58</fpage>&#x02013;<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/archneurol.2009.294">10.1001/archneurol.2009.294</ext-link></comment>
<pub-id pub-id-type="pmid">20065130</pub-id></mixed-citation></ref><ref id="pone.0164607.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Ceballos-Baumann</surname><given-names>AO</given-names></name>. <article-title>Functional imaging in Parkinson&#x02019;s disease: activation studies with PET, fMRI and SPECT</article-title>. <source>J Neurol</source>. <year>2003</year>;<volume>250</volume>: <fpage>i15</fpage>&#x02013;<lpage>i23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00415-003-1103-1">10.1007/s00415-003-1103-1</ext-link></comment>
<pub-id pub-id-type="pmid">12761630</pub-id></mixed-citation></ref><ref id="pone.0164607.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Brooks</surname><given-names>DJ</given-names></name>. <article-title>Functional imaging studies on dopamine and motor control</article-title>. <source>J Neural Transm</source>. <year>2001</year>;<volume>108</volume>: <fpage>1283</fpage>&#x02013;<lpage>1298</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s007020100005">10.1007/s007020100005</ext-link></comment>
<pub-id pub-id-type="pmid">11768627</pub-id></mixed-citation></ref><ref id="pone.0164607.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Fukuda</surname><given-names>M</given-names></name>, <name><surname>Edwards</surname><given-names>C</given-names></name>, <name><surname>Eidelberg</surname><given-names>D</given-names></name>. <article-title>Functional brain networks in Parkinson&#x02019;s disease</article-title>. <source>Parkinsonism Relat Disord</source>. <year>2001</year>;<volume>8</volume>: <fpage>91</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="pmid">11489673</pub-id></mixed-citation></ref><ref id="pone.0164607.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Brooks</surname><given-names>DJ</given-names></name>. <article-title>Motor disturbance and brain functional imaging in Parkinson&#x02019;s disease</article-title>. <source>Eur Neurol</source>. <year>1997</year>;<volume>38</volume>: <fpage>26</fpage>&#x02013;<lpage>32</lpage>.</mixed-citation></ref><ref id="pone.0164607.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Christopher</surname><given-names>L</given-names></name>, <name><surname>Strafella</surname><given-names>AP</given-names></name>. <article-title>Neuroimaging of brain changes associated with cognitive impairment in Parkinson&#x02019;s disease</article-title>. <source>J Neuropsychol</source>. <year>2013</year>;<volume>7</volume>: <fpage>225</fpage>&#x02013;<lpage>240</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/jnp.12015">10.1111/jnp.12015</ext-link></comment>
<pub-id pub-id-type="pmid">23551844</pub-id></mixed-citation></ref><ref id="pone.0164607.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Duncan</surname><given-names>GW</given-names></name>, <name><surname>Firbank</surname><given-names>MJ</given-names></name>, <name><surname>O&#x02019;Brien</surname><given-names>JT</given-names></name>, <name><surname>Burn</surname><given-names>DJ</given-names></name>. <article-title>Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson&#x02019;s disease</article-title>? <source>Mov Disord</source>. <year>2013</year>;<volume>28</volume>: <fpage>425</fpage>&#x02013;<lpage>438</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/mds.25352">10.1002/mds.25352</ext-link></comment>
<pub-id pub-id-type="pmid">23450518</pub-id></mixed-citation></ref><ref id="pone.0164607.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Carbon</surname><given-names>M</given-names></name>, <name><surname>Mari&#x000e9; R-</surname><given-names>M</given-names></name>. <article-title>Functional imaging of cognition in Parkinson&#x02019;s disease</article-title>. <source>Curr Opin Neurol</source>. <year>2003</year>;<volume>16</volume>: <fpage>475</fpage>&#x02013;<lpage>480</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/01.wco.0000084225.82329.3c">10.1097/01.wco.0000084225.82329.3c</ext-link></comment>
<pub-id pub-id-type="pmid">12869806</pub-id></mixed-citation></ref><ref id="pone.0164607.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Takeda</surname><given-names>A</given-names></name>, <name><surname>Saito</surname><given-names>N</given-names></name>, <name><surname>Baba</surname><given-names>T</given-names></name>, <name><surname>Kikuchi</surname><given-names>A</given-names></name>, <name><surname>Sugeno</surname><given-names>N</given-names></name>, <name><surname>Kobayashi</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Functional imaging studies of hyposmia in Parkinson&#x02019;s disease</article-title>. <source>J Neurol Sci</source>. <year>2010</year>;<volume>289</volume>: <fpage>36</fpage>&#x02013;<lpage>39</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jns.2009.08.041">10.1016/j.jns.2009.08.041</ext-link></comment>
<pub-id pub-id-type="pmid">19720385</pub-id></mixed-citation></ref><ref id="pone.0164607.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Boecker</surname><given-names>H</given-names></name>, <name><surname>Ceballos-Baumann</surname><given-names>A</given-names></name>, <name><surname>Bartenstein</surname><given-names>P</given-names></name>, <name><surname>Weindl</surname><given-names>A</given-names></name>, <name><surname>Siebner</surname><given-names>HR</given-names></name>, <name><surname>Fassbender</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Sensory processing in Parkinson&#x02019;s and Huntington's disease. Investigations with 3D H2 15O-PET</article-title>. <source>Brain</source>. <year>1999</year>;<volume>122</volume>: <fpage>1651</fpage>&#x02013;<lpage>1665</lpage>. <pub-id pub-id-type="pmid">10468505</pub-id></mixed-citation></ref><ref id="pone.0164607.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Stoessl</surname><given-names>AJ</given-names></name>. <article-title>Functional imaging studies of non-motoric manifestations of Parkinson&#x02019;s Disease</article-title>. <source>Parkinsonism Relat Disord</source>. <year>2009</year>;<volume>15</volume>
<issue>Suppl 3</issue>: <fpage>S13</fpage>&#x02013;<lpage>16</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1353-8020(09)70771-0">10.1016/S1353-8020(09)70771-0</ext-link></comment>
<pub-id pub-id-type="pmid">20082973</pub-id></mixed-citation></ref><ref id="pone.0164607.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Brefel-Courbon</surname><given-names>C</given-names></name>, <name><surname>Payoux</surname><given-names>P</given-names></name>, <name><surname>Thalamas</surname><given-names>C</given-names></name>, <name><surname>Ory</surname><given-names>F</given-names></name>, <name><surname>Quelven</surname><given-names>I</given-names></name>, <name><surname>Chollet</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Effect of levodopa on pain threshold in Parkinson&#x02019;s disease: a clinical and positron emission tomography study</article-title>. <source>Mov Disord</source>. <year>2005</year>;<volume>20</volume>: <fpage>1557</fpage>&#x02013;<lpage>1563</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/mds.20629">10.1002/mds.20629</ext-link></comment>
<pub-id pub-id-type="pmid">16078219</pub-id></mixed-citation></ref><ref id="pone.0164607.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Nolano</surname><given-names>M</given-names></name>, <name><surname>Provitera</surname><given-names>V</given-names></name>, <name><surname>Estraneo</surname><given-names>A</given-names></name>, <name><surname>Selim</surname><given-names>MM</given-names></name>, <name><surname>Caporaso</surname><given-names>G</given-names></name>, <name><surname>Stancanelli</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Sensory deficit in Parkinson&#x02019;s disease: Evidence of a cutaneous denervation</article-title>. <source>Brain</source>. <year>2008</year>;<volume>131</volume>: <fpage>1903</fpage>&#x02013;<lpage>1911</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/brain/awn102">10.1093/brain/awn102</ext-link></comment>
<pub-id pub-id-type="pmid">18515869</pub-id></mixed-citation></ref><ref id="pone.0164607.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Gibb</surname><given-names>WR</given-names></name>, <name><surname>Lees</surname><given-names>AJ</given-names></name>. <article-title>The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson&#x02019;s disease</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>1988</year>;<volume>51</volume>: <fpage>745</fpage>&#x02013;<lpage>752</lpage>. <pub-id pub-id-type="pmid">2841426</pub-id></mixed-citation></ref><ref id="pone.0164607.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Oldfield</surname><given-names>RC</given-names></name>. <article-title>The assessment and analysis of handedness: the Edinburgh inventory</article-title>. <source>Neuropsychologia</source>. <year>1971</year>;<volume>9</volume>: <fpage>97</fpage>&#x02013;<lpage>113</lpage>. <pub-id pub-id-type="pmid">5146491</pub-id></mixed-citation></ref><ref id="pone.0164607.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Leentjens</surname><given-names>AF</given-names></name>, <name><surname>Verhey</surname><given-names>FR</given-names></name>, <name><surname>Luijckx</surname><given-names>GJ</given-names></name>, <name><surname>Troost</surname><given-names>J</given-names></name>. <article-title>The validity of the Beck depression inventory as a screening and diagnostic instrument for depression in patients with Parkinson&#x02019;s disease</article-title>. <source>Mov Disord</source>. <year>2000</year>;<volume>15</volume>: <fpage>1221</fpage>&#x02013;<lpage>1224</lpage>. <pub-id pub-id-type="pmid">11104209</pub-id></mixed-citation></ref><ref id="pone.0164607.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Sheehan</surname><given-names>D V</given-names></name>, <name><surname>Lecrubier</surname><given-names>Y</given-names></name>, <name><surname>Sheehan</surname><given-names>KH</given-names></name>, <name><surname>Amorim</surname><given-names>P</given-names></name>, <name><surname>Janavs</surname><given-names>J</given-names></name>, <name><surname>Weiller</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title>. <source>J Clin Psychiatry</source>. <year>1998</year>;<volume>59</volume>: <fpage>22</fpage>&#x02013;<lpage>33</lpage>.</mixed-citation></ref><ref id="pone.0164607.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Folstein</surname><given-names>MF</given-names></name>, <name><surname>Folstein</surname><given-names>SE</given-names></name>, <name><surname>McHugh</surname><given-names>PR</given-names></name>. <article-title>&#x0201c;Mini-mental state&#x0201d;. A practical method for grading the cognitive state of patients for the clinician</article-title>. <source>J Psychiatr Res</source>. <year>1975</year>;<volume>12</volume>: <fpage>189</fpage>&#x02013;<lpage>198</lpage>. <pub-id pub-id-type="pmid">1202204</pub-id></mixed-citation></ref><ref id="pone.0164607.ref042"><label>42</label><mixed-citation publication-type="book"><name><surname>Schmidt</surname><given-names>K-H</given-names></name>, <name><surname>Metzler</surname><given-names>P</given-names></name>. <chapter-title>WST&#x02014;Wortschatztest</chapter-title>
<publisher-loc>Weinheim</publisher-loc>: <publisher-name>Beltz Test GmbH</publisher-name>; <year>1992</year>.</mixed-citation></ref><ref id="pone.0164607.ref043"><label>43</label><mixed-citation publication-type="book"><name><surname>Spielberger</surname><given-names>CD</given-names></name>, <name><surname>Gorsuch</surname><given-names>RL</given-names></name>, <name><surname>Lushene</surname><given-names>R</given-names></name>, <name><surname>Vagg</surname><given-names>PR</given-names></name>, <name><surname>Jacobs</surname><given-names>GA</given-names></name>. <source>Manual for the State-Trait Anxiety Inventory</source>. <publisher-loc>Palo Alto, CA</publisher-loc>: <publisher-name>Consulting Psychologists Press</publisher-name>; <year>1983</year>.</mixed-citation></ref><ref id="pone.0164607.ref044"><label>44</label><mixed-citation publication-type="book"><name><surname>Fahn</surname><given-names>S</given-names></name>, <name><surname>Elton</surname><given-names>RL</given-names></name>. <chapter-title>UPDRS Development Committee. The Unified Parkinson&#x02019;s Disease Rating Scale</chapter-title> In: <name><surname>Fahn</surname></name>, <name><surname>Marsden</surname><given-names>CD</given-names></name>, <name><surname>Calne</surname><given-names>DB</given-names></name>, <name><surname>Goldstein</surname><given-names>M</given-names></name>, editors. <source>Recent Developments in Parkinson&#x02019;s Disease</source>. <edition>2nd ed.</edition>
<publisher-loc>Florham Park, NJ</publisher-loc>: <publisher-name>Macmillan Healthcare Information</publisher-name>; <year>1987</year> pp. <fpage>153</fpage>&#x02013;<lpage>163</lpage>.</mixed-citation></ref><ref id="pone.0164607.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Hoehn</surname><given-names>MM</given-names></name>, <name><surname>Yahr</surname><given-names>MD</given-names></name>. <article-title>Parkinsonism: onset, progression, and mortality. 1967</article-title>. <source>Neurology</source>. <year>1998</year>;<volume>50</volume>: <fpage>318</fpage>&#x02013;<lpage>334</lpage>. <pub-id pub-id-type="pmid">9484345</pub-id></mixed-citation></ref><ref id="pone.0164607.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Kalbe</surname><given-names>E</given-names></name>, <name><surname>Calabrese</surname><given-names>P</given-names></name>, <name><surname>Kohn</surname><given-names>N</given-names></name>, <name><surname>Hilker</surname><given-names>R</given-names></name>, <name><surname>Riedel</surname><given-names>O</given-names></name>, <name><surname>Wittchen H-</surname><given-names>U</given-names></name>, <etal>et al</etal>
<article-title>Screening for cognitive deficits in Parkinson&#x02019;s disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument</article-title>. <source>Park Relat Disord</source>. <year>2008</year>;<volume>14</volume>: <fpage>93</fpage>&#x02013;<lpage>101</lpage>.</mixed-citation></ref><ref id="pone.0164607.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Wagner</surname><given-names>G</given-names></name>, <name><surname>Koschke</surname><given-names>M</given-names></name>, <name><surname>Leuf</surname><given-names>T</given-names></name>, <name><surname>Schl&#x000f6;sser</surname><given-names>R</given-names></name>, <name><surname>B&#x000e4;r</surname><given-names>KJ</given-names></name>. <article-title>Reduced heat pain thresholds after sad-mood induction are associated with changes in thalamic activity</article-title>. <source>Neuropsychologia</source>. <year>2009</year>;<volume>47</volume>: <fpage>980</fpage>&#x02013;<lpage>987</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neuropsychologia.2008.10.021">10.1016/j.neuropsychologia.2008.10.021</ext-link></comment>
<pub-id pub-id-type="pmid">19027763</pub-id></mixed-citation></ref><ref id="pone.0164607.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>B&#x000e4;r</surname><given-names>KJ</given-names></name>, <name><surname>Greiner</surname><given-names>W</given-names></name>, <name><surname>Letsch</surname><given-names>A</given-names></name>, <name><surname>K&#x000f6;bele</surname><given-names>R</given-names></name>, <name><surname>Sauer</surname><given-names>H</given-names></name>. <article-title>Influence of gender and hemispheric lateralization on heat pain perception in major depression</article-title>. <source>J Psychiatr Res</source>. <year>2003</year>;<volume>37</volume>: <fpage>345</fpage>&#x02013;<lpage>353</lpage>. <pub-id pub-id-type="pmid">12765857</pub-id></mixed-citation></ref><ref id="pone.0164607.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Bingel</surname><given-names>U</given-names></name>, <name><surname>Gl&#x000e4;scher</surname><given-names>J</given-names></name>, <name><surname>Weiller</surname><given-names>C</given-names></name>, <name><surname>B&#x000fc;chel</surname><given-names>C</given-names></name>. <article-title>Somatotopic representation of nociceptive information in the putamen: An event-related fMRI study</article-title>. <source>Cereb Cortex</source>. <year>2004</year>;<volume>14</volume>: <fpage>1340</fpage>&#x02013;<lpage>1345</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/cercor/bhh094">10.1093/cercor/bhh094</ext-link></comment>
<pub-id pub-id-type="pmid">15217895</pub-id></mixed-citation></ref><ref id="pone.0164607.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Bingel</surname><given-names>U</given-names></name>, <name><surname>Lorenz</surname><given-names>J</given-names></name>, <name><surname>Glauche</surname><given-names>V</given-names></name>, <name><surname>Knab</surname><given-names>R</given-names></name>, <name><surname>Gl&#x000e4;scher</surname><given-names>J</given-names></name>, <name><surname>Weiller</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Somatotopic organization of human somatosensory cortices for pain: A single trial fMRI study</article-title>. <source>Neuroimage</source>. <year>2004</year>;<volume>23</volume>: <fpage>224</fpage>&#x02013;<lpage>232</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neuroimage.2004.05.021">10.1016/j.neuroimage.2004.05.021</ext-link></comment>
<pub-id pub-id-type="pmid">15325369</pub-id></mixed-citation></ref><ref id="pone.0164607.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Helmchen</surname><given-names>C</given-names></name>, <name><surname>Mohr</surname><given-names>C</given-names></name>, <name><surname>Roehl</surname><given-names>M</given-names></name>, <name><surname>Bingel</surname><given-names>U</given-names></name>, <name><surname>Lorenz</surname><given-names>J</given-names></name>, <name><surname>B&#x000fc;chel</surname><given-names>C</given-names></name>. <article-title>Common neural systems for contact heat and laser pain stimulation reveal higher-level pain processing</article-title>. <source>Hum Brain Mapp</source>. <year>2008</year>;<volume>29</volume>: <fpage>1080</fpage>&#x02013;<lpage>1091</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/hbm.20447">10.1002/hbm.20447</ext-link></comment>
<pub-id pub-id-type="pmid">17924552</pub-id></mixed-citation></ref><ref id="pone.0164607.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Eickhoff</surname><given-names>SB</given-names></name>, <name><surname>Paus</surname><given-names>T</given-names></name>, <name><surname>Caspers</surname><given-names>S</given-names></name>, <name><surname>Grosbras</surname><given-names>MH</given-names></name>, <name><surname>Evans</surname><given-names>AC</given-names></name>, <name><surname>Zilles</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Assignment of functional activations to probabilistic cytoarchitectonic areas revisited</article-title>. <source>Neuroimage</source>. <year>2007</year>;<volume>36</volume>: <fpage>511</fpage>&#x02013;<lpage>521</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neuroimage.2007.03.060">10.1016/j.neuroimage.2007.03.060</ext-link></comment>
<pub-id pub-id-type="pmid">17499520</pub-id></mixed-citation></ref><ref id="pone.0164607.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Fowles</surname><given-names>DC</given-names></name>, <name><surname>Christie</surname><given-names>MJ</given-names></name>, <name><surname>Edelberg</surname><given-names>R</given-names></name>, <name><surname>Grings</surname><given-names>WW</given-names></name>, <name><surname>Lykken</surname><given-names>DT</given-names></name>, <name><surname>Venables</surname><given-names>PH</given-names></name>. <article-title>Committee report. Publication recommendations for electrodermal measurements</article-title>. <source>Psychophysiology</source>. <year>1981</year>;<volume>18</volume>: <fpage>232</fpage>&#x02013;<lpage>239</lpage>. <pub-id pub-id-type="pmid">7291438</pub-id></mixed-citation></ref><ref id="pone.0164607.ref054"><label>54</label><mixed-citation publication-type="book"><name><surname>Dawson</surname><given-names>ME</given-names></name>, <name><surname>Schell</surname><given-names>AM</given-names></name>, <name><surname>Filion</surname><given-names>DL</given-names></name>. <chapter-title>The electrodermal system</chapter-title> In: <name><surname>Cacioppo</surname><given-names>JT</given-names></name>, <name><surname>Tassinary</surname><given-names>LG</given-names></name>, <name><surname>Berntson</surname><given-names>GG</given-names></name>, editors. <source>Handbook of Psychophysiology</source>. <edition>3rd ed.</edition>
<publisher-loc>Cambridge, New York, Melbourne, Madrid, Cape Town, Singapore, Sao Paulo</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>; <year>2007</year> pp. <fpage>159</fpage>&#x02013;<lpage>181</lpage>.</mixed-citation></ref><ref id="pone.0164607.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Raichle</surname><given-names>ME</given-names></name>, <name><surname>MacLeod</surname><given-names>AM</given-names></name>, <name><surname>Snyder</surname><given-names>AZ</given-names></name>, <name><surname>Powers</surname><given-names>WJ</given-names></name>, <name><surname>Gusnard</surname><given-names>DA</given-names></name>, <name><surname>Shulman</surname><given-names>GL</given-names></name>. <article-title>A default mode of brain function</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2001</year>;<volume>98</volume>: <fpage>676</fpage>&#x02013;<lpage>682</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.98.2.676">10.1073/pnas.98.2.676</ext-link></comment>
<pub-id pub-id-type="pmid">11209064</pub-id></mixed-citation></ref><ref id="pone.0164607.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Raichle</surname><given-names>ME</given-names></name>, <name><surname>Snyder</surname><given-names>AZ</given-names></name>. <article-title>A default mode of brain function: A brief history of an evolving idea</article-title>. <source>Neuroimage</source>. <year>2007</year>;<volume>37</volume>: <fpage>1083</fpage>&#x02013;<lpage>1090</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neuroimage.2007.02.041">10.1016/j.neuroimage.2007.02.041</ext-link></comment>
<pub-id pub-id-type="pmid">17719799</pub-id></mixed-citation></ref><ref id="pone.0164607.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>N&#x000e8;gre-Pag&#x000e8;s</surname><given-names>L</given-names></name>, <name><surname>Grandjean</surname><given-names>H</given-names></name>, <name><surname>Lapeyre-Mestre</surname><given-names>M</given-names></name>, <name><surname>Montastruc</surname><given-names>JL</given-names></name>, <name><surname>Fourrier</surname><given-names>A</given-names></name>, <name><surname>L&#x000e9;pine</surname><given-names>JP</given-names></name>, <etal>et al</etal>
<article-title>Anxious and depressive symptoms in Parkinson&#x02019;s disease: the French cross-sectionnal DoPaMiP study</article-title>. <source>Mov Disord</source>. <year>2010</year>;<volume>25</volume>: <fpage>157</fpage>&#x02013;<lpage>166</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/mds.22760">10.1002/mds.22760</ext-link></comment>
<pub-id pub-id-type="pmid">19950403</pub-id></mixed-citation></ref><ref id="pone.0164607.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Richard</surname><given-names>IH</given-names></name>. <article-title>Anxiety disorders in Parkinson&#x02019;s disease</article-title>. <source>Adv Neurol</source>. <year>2005</year>;<volume>96</volume>: <fpage>42</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="pmid">16383211</pub-id></mixed-citation></ref><ref id="pone.0164607.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Ehrt</surname><given-names>U</given-names></name>, <name><surname>Larsen</surname><given-names>JP</given-names></name>, <name><surname>Aarsland</surname><given-names>D</given-names></name>. <article-title>Pain and its relationship to depression in Parkinson disease</article-title>. <source>Am J Geriatr Psychiatry</source>. <year>2009</year>;<volume>17</volume>: <fpage>269</fpage>&#x02013;<lpage>275</lpage>. <pub-id pub-id-type="pmid">19322934</pub-id></mixed-citation></ref><ref id="pone.0164607.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Henderson</surname><given-names>R</given-names></name>, <name><surname>Kurlan</surname><given-names>R</given-names></name>, <name><surname>Kersun</surname><given-names>JM</given-names></name>, <name><surname>Como</surname><given-names>P</given-names></name>. <article-title>Preliminary examination of the comorbidity of anxiety and depression in Parkinson&#x02019;s disease</article-title>. <source>J Neuropsychiatry Clin Neurosci</source>. <year>1992</year>;<volume>4</volume>: <fpage>257</fpage>&#x02013;<lpage>264</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1176/jnp.4.3.257">10.1176/jnp.4.3.257</ext-link></comment>
<pub-id pub-id-type="pmid">1498578</pub-id></mixed-citation></ref><ref id="pone.0164607.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Nuti</surname><given-names>A</given-names></name>, <name><surname>Ceravolo</surname><given-names>R</given-names></name>, <name><surname>Piccinni</surname><given-names>A</given-names></name>, <name><surname>Dell&#x02019;Agnello</surname><given-names>G</given-names></name>, <name><surname>Bellini</surname><given-names>G</given-names></name>, <name><surname>Gambaccini</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Psychiatric comorbidity in a population of Parkinson&#x02019;s disease patients</article-title>. <source>Eur J Neurol</source>. <year>2004</year>;<volume>11</volume>: <fpage>315</fpage>&#x02013;<lpage>320</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1468-1331.2004.00781.x">10.1111/j.1468-1331.2004.00781.x</ext-link></comment>
<pub-id pub-id-type="pmid">15142224</pub-id></mixed-citation></ref><ref id="pone.0164607.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Rutten</surname><given-names>S</given-names></name>, <name><surname>Ghielen</surname><given-names>I</given-names></name>, <name><surname>Vriend</surname><given-names>C</given-names></name>, <name><surname>Hoogendoorn</surname><given-names>AW</given-names></name>, <name><surname>Berendse</surname><given-names>HW</given-names></name>, <name><surname>Leentjens</surname><given-names>AFG</given-names></name>, <etal>et al</etal>
<article-title>Anxiety in Parkinson&#x02019;s disease: Symptom dimensions and overlap with depression and autonomic failure</article-title>. <source>Park Relat Disord</source>. <year>2014</year>;<volume>21</volume>: <fpage>189</fpage>&#x02013;<lpage>193</lpage>.</mixed-citation></ref><ref id="pone.0164607.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Yamanishi</surname><given-names>T</given-names></name>, <name><surname>Tachibana</surname><given-names>H</given-names></name>, <name><surname>Oguru</surname><given-names>M</given-names></name>, <name><surname>Matsui</surname><given-names>K</given-names></name>, <name><surname>Toda</surname><given-names>K</given-names></name>, <name><surname>Okuda</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Anxiety and depression in patients with Parkinson&#x02019;s disease</article-title>. <source>Intern Med</source>. <year>2013</year>;<volume>52</volume>: <fpage>539</fpage>&#x02013;<lpage>545</lpage>. <pub-id pub-id-type="pmid">23448761</pub-id></mixed-citation></ref><ref id="pone.0164607.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Djaldetti</surname><given-names>R</given-names></name>, <name><surname>Shifrin</surname><given-names>A</given-names></name>, <name><surname>Rogowski</surname><given-names>Z</given-names></name>, <name><surname>Sprecher</surname><given-names>E</given-names></name>, <name><surname>Melamed</surname><given-names>E</given-names></name>, <name><surname>Yarnitsky</surname><given-names>D</given-names></name>. <article-title>Quantitative measurement of pain sensation in patients with Parkinson disease</article-title>. <source>Neurology</source>. <year>2004</year>;<volume>62</volume>: <fpage>2171</fpage>&#x02013;<lpage>2175</lpage>. <pub-id pub-id-type="pmid">15210877</pub-id></mixed-citation></ref><ref id="pone.0164607.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Gerdelat-Mas</surname><given-names>A</given-names></name>, <name><surname>Simonetta-Moreau</surname><given-names>M</given-names></name>, <name><surname>Thalamas</surname><given-names>C</given-names></name>, <name><surname>Ory-Magne</surname><given-names>F</given-names></name>, <name><surname>Slaoui</surname><given-names>T</given-names></name>, <name><surname>Rascol</surname><given-names>O</given-names></name>, <etal>et al</etal>
<article-title>Levodopa raises objective pain threshold in Parkinson&#x02019;s disease: a RIII reflex study</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>2007</year>;<volume>78</volume>: <fpage>1140</fpage>&#x02013;<lpage>1142</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/jnnp.2007.120212">10.1136/jnnp.2007.120212</ext-link></comment>
<pub-id pub-id-type="pmid">17504881</pub-id></mixed-citation></ref><ref id="pone.0164607.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Zambito Marsala</surname><given-names>S</given-names></name>, <name><surname>Tinazzi</surname><given-names>M</given-names></name>, <name><surname>Vitaliani</surname><given-names>R</given-names></name>, <name><surname>Recchia</surname><given-names>S</given-names></name>, <name><surname>Fabris</surname><given-names>F</given-names></name>, <name><surname>Marchini</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Spontaneous pain, pain threshold, and pain tolerance in Parkinson&#x02019;s disease</article-title>. <source>J Neurol</source>. <year>2011</year>;<volume>258</volume>: <fpage>627</fpage>&#x02013;<lpage>633</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00415-010-5812-0">10.1007/s00415-010-5812-0</ext-link></comment>
<pub-id pub-id-type="pmid">21082324</pub-id></mixed-citation></ref><ref id="pone.0164607.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Urakami</surname><given-names>K</given-names></name>, <name><surname>Takahashi</surname><given-names>K</given-names></name>, <name><surname>Matsushima</surname><given-names>E</given-names></name>, <name><surname>Sano</surname><given-names>K</given-names></name>, <name><surname>Nishikawa</surname><given-names>S</given-names></name>, <name><surname>Takao</surname><given-names>T</given-names></name>. <article-title>The threshold of pain and neurotransmitter&#x02019;s change on pain in Parkinson's disease</article-title>. <source>Jpn J Psychiatry Neurol</source>. <year>1990</year>;<volume>44</volume>: <fpage>589</fpage>&#x02013;<lpage>593</lpage>. <pub-id pub-id-type="pmid">1705999</pub-id></mixed-citation></ref><ref id="pone.0164607.ref068"><label>68</label><mixed-citation publication-type="journal"><name><surname>Guieu</surname><given-names>R</given-names></name>, <name><surname>Pouget</surname><given-names>J</given-names></name>, <name><surname>Serratrice</surname><given-names>G</given-names></name>. <article-title>Nociceptive threshold and Parkinson disease</article-title>. <source>Rev Neurol (Paris)</source>. <year>1992</year>;<volume>148</volume>: <fpage>641</fpage>&#x02013;<lpage>644</lpage>.<pub-id pub-id-type="pmid">1295061</pub-id></mixed-citation></ref><ref id="pone.0164607.ref069"><label>69</label><mixed-citation publication-type="journal"><name><surname>Tinazzi</surname><given-names>M</given-names></name>, <name><surname>Del Vesco</surname><given-names>C</given-names></name>, <name><surname>Defazio</surname><given-names>G</given-names></name>, <name><surname>Fincati</surname><given-names>E</given-names></name>, <name><surname>Smania</surname><given-names>N</given-names></name>, <name><surname>Moretto</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Abnormal processing of the nociceptive input in Parkinson&#x02019;s disease: A study with CO2 laser evoked potentials</article-title>. <source>Pain</source>. <year>2008</year>;<volume>136</volume>: <fpage>117</fpage>&#x02013;<lpage>124</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.pain.2007.06.022">10.1016/j.pain.2007.06.022</ext-link></comment>
<pub-id pub-id-type="pmid">17765400</pub-id></mixed-citation></ref><ref id="pone.0164607.ref070"><label>70</label><mixed-citation publication-type="journal"><name><surname>Apkarian</surname><given-names>AV</given-names></name>, <name><surname>Bushnell</surname><given-names>MC</given-names></name>, <name><surname>Treede</surname><given-names>R-D</given-names></name>, <name><surname>Zubieta</surname><given-names>J-K</given-names></name>. <article-title>Human brain mechanisms of pain perception and regulation in health and disease</article-title>. <source>Eur J Pain</source>. <year>2005</year>;<volume>9</volume>: <fpage>463</fpage>&#x02013;<lpage>484</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejpain.2004.11.001">10.1016/j.ejpain.2004.11.001</ext-link></comment>
<pub-id pub-id-type="pmid">15979027</pub-id></mixed-citation></ref><ref id="pone.0164607.ref071"><label>71</label><mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>KD</given-names></name>. <article-title>The neural circuitry of pain as explored with functional MRI</article-title>. <source>Neurol Res</source>. <year>2000</year>;<volume>22</volume>: <fpage>313</fpage>&#x02013;<lpage>317</lpage>. <pub-id pub-id-type="pmid">10769826</pub-id></mixed-citation></ref><ref id="pone.0164607.ref072"><label>72</label><mixed-citation publication-type="journal"><name><surname>Duerden</surname><given-names>EG</given-names></name>, <name><surname>Albanese</surname><given-names>MC</given-names></name>. <article-title>Localization of pain-related brain activation: A meta-analysis of neuroimaging data</article-title>. <source>Hum Brain Mapp</source>. <year>2013</year>;<volume>34</volume>: <fpage>109</fpage>&#x02013;<lpage>149</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/hbm.21416">10.1002/hbm.21416</ext-link></comment>
<pub-id pub-id-type="pmid">22131304</pub-id></mixed-citation></ref><ref id="pone.0164607.ref073"><label>73</label><mixed-citation publication-type="journal"><name><surname>Peyron</surname><given-names>R</given-names></name>, <name><surname>Laurent</surname><given-names>B</given-names></name>, <name><surname>Garc&#x000ed;a-Larrea</surname><given-names>L</given-names></name>. <article-title>Functional imaging of brain responses to pain. A review and meta-analysis (2000)</article-title>. <source>Neurophysiol Clin</source>. <year>2000</year>;<volume>30</volume>: <fpage>263</fpage>&#x02013;<lpage>288</lpage>. <pub-id pub-id-type="pmid">11126640</pub-id></mixed-citation></ref><ref id="pone.0164607.ref074"><label>74</label><mixed-citation publication-type="journal"><name><surname>Tracey</surname><given-names>I</given-names></name>, <name><surname>Mantyh</surname><given-names>PW</given-names></name>. <article-title>The cerebral signature for pain perception and its modulation</article-title>. <source>Neuron</source>. <year>2007</year>;<volume>55</volume>: <fpage>377</fpage>&#x02013;<lpage>391</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neuron.2007.07.012">10.1016/j.neuron.2007.07.012</ext-link></comment>
<pub-id pub-id-type="pmid">17678852</pub-id></mixed-citation></ref><ref id="pone.0164607.ref075"><label>75</label><mixed-citation publication-type="journal"><name><surname>Baumg&#x000e4;rtner</surname><given-names>U</given-names></name>, <name><surname>Iannetti</surname><given-names>GD</given-names></name>, <name><surname>Zambreanu</surname><given-names>L</given-names></name>, <name><surname>Stoeter</surname><given-names>P</given-names></name>, <name><surname>Treede</surname><given-names>R-D</given-names></name>, <name><surname>Tracey</surname><given-names>I</given-names></name>. <article-title>Multiple somatotopic representations of heat and mechanical pain in the operculo-insular cortex: a high-resolution fMRI study</article-title>. <source>J Neurophysiol</source>. <year>2010</year>;<volume>104</volume>: <fpage>2863</fpage>&#x02013;<lpage>2872</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/jn.00253.2010">10.1152/jn.00253.2010</ext-link></comment>
<pub-id pub-id-type="pmid">20739597</pub-id></mixed-citation></ref><ref id="pone.0164607.ref076"><label>76</label><mixed-citation publication-type="journal"><name><surname>Del Gratta</surname><given-names>C</given-names></name>, <name><surname>Della Penna</surname><given-names>S</given-names></name>, <name><surname>Ferretti</surname><given-names>A</given-names></name>, <name><surname>Franciotti</surname><given-names>R</given-names></name>, <name><surname>Pizzella</surname><given-names>V</given-names></name>, <name><surname>Tartaro</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Topographic organization of the human primary and secondary somatosensory cortices: comparison of fMRI and MEG findings</article-title>. <source>Neuroimage</source>. <year>2002</year>;<volume>17</volume>: <fpage>1373</fpage>&#x02013;<lpage>1383</lpage>. <pub-id pub-id-type="pmid">12414277</pub-id></mixed-citation></ref><ref id="pone.0164607.ref077"><label>77</label><mixed-citation publication-type="journal"><name><surname>Greenspan</surname><given-names>JD</given-names></name>, <name><surname>Lee</surname><given-names>RR</given-names></name>, <name><surname>Lenz</surname><given-names>FA</given-names></name>. <article-title>Pain sensitivity alterations as a function of lesion location in the parasylvian cortex</article-title>. <source>Pain</source>. <year>1999</year>;<volume>81</volume>: <fpage>273</fpage>&#x02013;<lpage>282</lpage>. <pub-id pub-id-type="pmid">10431714</pub-id></mixed-citation></ref><ref id="pone.0164607.ref078"><label>78</label><mixed-citation publication-type="journal"><name><surname>Delaveau</surname><given-names>P</given-names></name>, <name><surname>Salgado-Pineda</surname><given-names>P</given-names></name>, <name><surname>Fossati</surname><given-names>P</given-names></name>, <name><surname>Witjas</surname><given-names>T</given-names></name>, <name><surname>Azulay</surname><given-names>JP</given-names></name>, <name><surname>Blin</surname><given-names>O</given-names></name>. <article-title>Dopaminergic modulation of the default mode network in Parkinson&#x02019;s disease</article-title>. <source>Eur Neuropsychopharmacol</source>. <year>2010</year>;<volume>20</volume>: <fpage>784</fpage>&#x02013;<lpage>792</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.euroneuro.2010.07.001">10.1016/j.euroneuro.2010.07.001</ext-link></comment>
<pub-id pub-id-type="pmid">20674286</pub-id></mixed-citation></ref><ref id="pone.0164607.ref079"><label>79</label><mixed-citation publication-type="journal"><name><surname>van Eimeren</surname><given-names>T</given-names></name>, <name><surname>Monchi</surname><given-names>O</given-names></name>, <name><surname>Ballanger</surname><given-names>B</given-names></name>, <name><surname>Strafella</surname><given-names>AP</given-names></name>. <article-title>Dysfunction of the default mode network in Parkinson disease: a functional magnetic resonance imaging study</article-title>. <source>Arch Neurol</source>. <year>2009</year>;<volume>66</volume>: <fpage>877</fpage>&#x02013;<lpage>883</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/archneurol.2009.97">10.1001/archneurol.2009.97</ext-link></comment>
<pub-id pub-id-type="pmid">19597090</pub-id></mixed-citation></ref><ref id="pone.0164607.ref080"><label>80</label><mixed-citation publication-type="journal"><name><surname>Agosta</surname><given-names>F</given-names></name>, <name><surname>Pievani</surname><given-names>M</given-names></name>, <name><surname>Geroldi</surname><given-names>C</given-names></name>, <name><surname>Copetti</surname><given-names>M</given-names></name>, <name><surname>Frisoni</surname><given-names>GB</given-names></name>, <name><surname>Filippi</surname><given-names>M</given-names></name>. <article-title>Resting state fMRI in Alzheimer&#x02019;s disease: Beyond the default mode network</article-title>. <source>Neurobiol Aging</source>. <year>2012</year>;<volume>33</volume>: <fpage>1564</fpage>&#x02013;<lpage>1578</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neurobiolaging.2011.06.007">10.1016/j.neurobiolaging.2011.06.007</ext-link></comment>
<pub-id pub-id-type="pmid">21813210</pub-id></mixed-citation></ref><ref id="pone.0164607.ref081"><label>81</label><mixed-citation publication-type="journal"><name><surname>Sambataro</surname><given-names>F</given-names></name>, <name><surname>Murty</surname><given-names>VP</given-names></name>, <name><surname>Callicott</surname><given-names>JH</given-names></name>, <name><surname>Tan</surname><given-names>HY</given-names></name>, <name><surname>Das</surname><given-names>S</given-names></name>, <name><surname>Weinberger</surname><given-names>DR</given-names></name>, <etal>et al</etal>
<article-title>Age-related alterations in default mode network: Impact on working memory performance</article-title>. <source>Neurobiol Aging</source>. <year>2010</year>;<volume>31</volume>: <fpage>839</fpage>&#x02013;<lpage>852</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neurobiolaging.2008.05.022">10.1016/j.neurobiolaging.2008.05.022</ext-link></comment>
<pub-id pub-id-type="pmid">18674847</pub-id></mixed-citation></ref><ref id="pone.0164607.ref082"><label>82</label><mixed-citation publication-type="journal"><name><surname>Broyd</surname><given-names>SJ</given-names></name>, <name><surname>Demanuele</surname><given-names>C</given-names></name>, <name><surname>Debener</surname><given-names>S</given-names></name>, <name><surname>Helps</surname><given-names>SK</given-names></name>, <name><surname>James</surname><given-names>CJ</given-names></name>, <name><surname>Sonuga-Barke</surname><given-names>EJS</given-names></name>. <article-title>Default-mode brain dysfunction in mental disorders: A systematic review</article-title>. <source>Neurosci Biobehav Rev</source>. <year>2009</year>;<volume>33</volume>: <fpage>279</fpage>&#x02013;<lpage>296</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neubiorev.2008.09.002">10.1016/j.neubiorev.2008.09.002</ext-link></comment>
<pub-id pub-id-type="pmid">18824195</pub-id></mixed-citation></ref><ref id="pone.0164607.ref083"><label>83</label><mixed-citation publication-type="journal"><name><surname>Buckner</surname><given-names>RL</given-names></name>, <name><surname>Andrews-Hanna</surname><given-names>JR</given-names></name>, <name><surname>Schacter</surname><given-names>DL</given-names></name>. <article-title>The brain&#x02019;s default network: anatomy, function, and relevance to disease</article-title>. <source>Ann N Y Acad Sci</source>. <year>2008</year>;<volume>1124</volume>: <fpage>1</fpage>&#x02013;<lpage>38</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1196/annals.1440.011">10.1196/annals.1440.011</ext-link></comment>
<pub-id pub-id-type="pmid">18400922</pub-id></mixed-citation></ref></ref-list></back></article>